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ABSTRACT
Chromatin remodelig is crucial to transcriptional regulation in vivo and a
number of protein complexes capable of alterig genomic architecture in the
budding yeast Saccaromyces cerevisia have been identifed. Among these, the
SWI/SNF complex, a 2 MDa, eleven subunit protein assembly, has been the most
extensively characteried. The SWI/SNF complex is requied for the proper
expression of a number of genes in yeast, although it is completely dispensable for
the expression of others. Likewise, some, but not al, transcriptional activator
proteins require SWI/SNF activity in order to function in vivo. The goal of this
thesis work was to identif those components of the transcription process which
dictate this dependence on SWI/SNF activity.
Using the well characterized UASGAL system, we have determined that one 
of these components is the nucleosome. state of activator binding sites within a
promoter. We fid that whie SWI/SNF activity is not required for the GAL4
activator to bind to and activate transcription from nucleosome-free binding sites,
the complex is required for GAL4 to bind and function at low affnity, nucleosomal
binding sites in vivo. The SWI/SNF -dependence of these nucleosomal bindig
sites can be overcome by 1) replacing the low afnity sites with higher afity,
consensus GAL4 binding sequences, or 2) placing the low afnity sites into a
nucleos me- ree region. These results provide the fist in vivo evidence that the
SWI/SNF complex can reguate gene expression by modulating the DNA binding of
a transcriptional activator protein.
To determine whether specifc components of the GAL4 protein are
necessary in order for the SWI/SNF complex to modulate binding to nucleosomal
sites in our model system , we tested the SWI/SNF dependent DNA binding of
various derivative GAL4 proteins. We find that a functional activation domain 
not required for SWI/SNF to modulate GAL4 binding in vivo. Interestingly, like
the ful length protein GAL4 derivatives in which the activation domai has been
mutated are able to partialy occupy nucleosomal sites in the absence of SWI/SNF
(bindig in the absence of SWI/SNF is at least forty percent lower than in the
presence of SWIISNF), indicating the activation domain is also not required for
SWIISNF-independent DNA bindig.
These results support a model in which the SWI/SNF dependence of a gene
reflects the nucleosomal context of its important reguatory sequences , e.g. binding
sites for transcriptional regulatory proteins. Although nucleosomal promoter
regions have been correlated with SWIISNF -dependence in the past, there has of
yet been no gene at which nucleosome location has correlated with a specifc
genetic function. In the fial part of this thesis work, we initiated a search for an
endogenous SWIISNF -dependent gene for which the nucleosome state of activator
binding sites could be determined.
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CHATER I
INTRODUCTION
Transcription and its regulation
The nucleus of the buddig yeast Saccharomyces cerevisiae houses 1400 kb
of DNA and over 6500 open readig frames (Guthrie and Fink, 1991). If expressed
at the appropriate time durig the lie of the cell and in amounts appropriate to
specifc envionmental and developmental cues, these genes alow the yeast cell to
grow and reproduce normaly. Any interference in the expression of this genetic
information , however, can have disastrous consequences for the cell. It is
therefore not surprising that transcription, the process by which al eukaryotic
cells access genetic information, is tightly regulated. The mechanisms of this
regulation, and of the transcription process itself, are highly conserved among
eukaryotes.
The past decade has seen an incredible amount of research in the field of
eukaryotic gene expression and the fruits of these labors have iluminated the
basic mechanisms of the transcription process for protein -codig (class II) genes
(review:d in Zawel and Reinberg, 1993 and Zawel and Reinberg, 1995). The most
crucial genetic component of the class II gene is the open readig frame, which
serves as the template for mRNA production by RNA polymerase II (RNAPII), the
enzyme responsible for transcribing these genes. In addition to an open readig
frame, class II genes contain a number of reguatory sequences which both promote
(promoter regions) and reguate (enhancer elements and silencer elements) their
transcription. Minimaly, a promoter region contains a TAT A box and/or an
initiator (Inr) element; these DNA sequences direct RNAPII and the rest of the
transcription machinery to the proper site for transcription initiation. Enhancers
(often caled upstream activation sequences or simply UAS in lower eukaryotes)
are genetic reguatory elements which function as bindig sites for sequence-
specifc DNA bindig proteins. Enhancers are often located far from the
transcription start site and core promoter elements , yet the proteins which bind to
these regions are able to profoundly afect the process of transcription. Whe core
promoter elements are universal, the more distal enhancer or UAS elements are
gene-specifc. Together these reguatory sequences help the cell' s transcription
machinery to express proper amounts of a given gene at the appropriate time in
the lie cycle of a cell.
In addition to RNAPII, the transcription apparatus consists of a dizzying
array of both general transcription factors (GTFs) and regulatory proteins
(activators , repressors , mediators and coactivators). The proper interplay of these
proteins with each other and with the genetic reguatory components described
above is crucial to proper gene expression. Furthermore, this myriad of protein-
protein and protein-DNA interactions provides ample opportunity for the cell to
tightly reguate transcription.
In vitro, basal gene expression typicaly requires a DNA template (codig
sequence and a core promoter), RNAPII, the GTFs TATA binding protein (TBP),
TFIIB, TFIIF, TFIIE , TFIIH, ribonucleotides and ATP (Zawel and Reinberg, 1995
and references therein). Careful dissection of this in vitro system has determined
that transcription begins with the precisely choreographed assembly of the GTFs
into a preinitiation complex (PIC) at the core promoter (Buratowski et al, 1989;
see Figure l-1A). PIC assenibly is nucleated by the binding ofTFIID (TBP and its
associated TAFs) to the TATA box, which is typicaly located thirty basepairs
upstream of the transcription start site (Buratowski et al, 1989; Kim et al, 1993).
TFIIB enters the complex next by recognzing and bindig to promoter-bound TBP
(Buratowski et al, 1989; Nikolov et al, 1995). TFIIB has been implicated in start
site selection (pinto et al, 1992; Lagrange et al, 1996) and is thought to guide
RNAPII to the 'proper promoter location via a diect interaction with one of
RNAPII' s eleven subunits (Li et al, 1994). TFIIF enters the complex at the same
time as RNAPII , suggesting that it is also involved in RNAPII recruitment
(Buratowski et al, 1989; Kieen et al, 1992). TFIIE and TFIIH appear to enter the
complex afer RNAPII and TFIIF and since transcription initiation can occur in
their absence, these factors are thought to be involved in transcriptional
elongation (reviewed in Drapki and Reinberg, 1994). In support of this notion
TFIIH as a kiase activity capable of phosphorylating the carboxy-terminal
domai (CTD) ofRNAPII and it is the phosphorylated form ofRNAPII which
seems to be involved in elongation (Laybourn and Dahmus, 1990). Furthermore,
,,,
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TBP Inr
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Figure 1-1. Preinitiation complex assembly on a eukaryotic promoter.
Panel A (previous page), Stepwise assembly pathway. Panel B Holoenzyme
recruitment pathway. Horizontal line depicts a typical eukaryotic promoter with
TATA indicating the TATA element, Inr indicating the initiator element, bent
arrow indicating the transcription start site and the closed boxes representing
upstream activator binding sites. Shapes represent the indicated general trans-
cription factors.
in vitro studies indicate TFIIE may modulate TFIIH activity (Hua et al, 1992;
reviewed in Svejstrup et al, 1996). Finaly, the GTF TFIIA deserves special
comment. Although its role in PIC formation has historicaly been enigmatic
recent studies indicate TFIIA plays a primariy reguatory role in the initiation of
transcription (reviewed in Roeder, 1996 and Nikolov and Burley, 1997). TFIIA
recognzes the TBP-TATA element complex in vitro and is required for stable TBP
binding at some (but not al) promoters in vivo. This varabilty in TFIIA
requirement may reflect the intrinsic TBP-binding properties of individual
promoters.
There are two notable exceptions to the PIC assembly pathway described
above. First, the promoters of some class II genes do not contain a TATA element.
For these genes, PIC nucleation appears to occur over the Inr element, which
encompasses the transcription start site (Smale and Baltimore, 1989). It is
believed that TBP as well as its associated factors (TAFs) are recruited to the PIC
ofTATA-less promoters by interactions with proteins which bind to the Inr
(reviewed in Weis and Reinberg, 1992 and Roeder, 1996). Secondly, the isolation
of stable RNAPII-containg complexes that contai many of the general
transcription factors suggests PICs may exist preassembled in vivo and that for
some genes this entire assembly may arrive at the promoter at once (Km et al
1994; aldonado et al, 1996; see Figure I- IB).
However the PIC comes to be assembled at the promoter, the end result of
its presence in vitro is transcription initiation and basal gene expression. Since
the genome is compacted into a chromatin structure which is inhibitory to
transcription (see below), and because the majority of transcription factors are
likely to be limiting in the nuclear mileu , it is unlikely that "basal" expression
exists in vivo. Instead, gene expression within the eukaryotic nucleus is thought to
be absolutely dependent upon the activity of gene-specifc activator proteins.
Activator proteins are typicaly modular: their two essential activities,
promoter-binding and transcriptional activation, are conferred by distinct and
separable domais (Keegan et al, 1986; Giniger and Ptashne, 1987). In addition
to these functional domains, an activator protein requires promoter binding sites
in order to properly activate the expression of a gene under its control. These
binding sites can be found close to (proximal) or far from (distal) the core
promoter. By associating with proximal promoter binding sites , the DNA binding
domain wi bring the activation domain into the general vicinity of the core
promoter region, where the PIC is being assembled. Once there, the activation
domain is thought to inuence the rate and/or effciency of PIC assembly, and
therefore of gene expression, by interacting with one or more of the GTFs. These
activator-GTF interactions are believed to stimulate transcription even when
activator binding sites are located far from the core promoter; in these cases the
DNA located between the distal activator binding sequences and the core
promoter region provides a flexible tether which, when looped, can accommodate
activator-PIC interactions (ptashne, 1988; Ptashne and Gann , 1997).
Incidentaly, activator-PIC interactions need not be diect; a number of
biochemical activities (reviewed in Koleske and Young, 1995) have been found to
mediate transcriptional activation and may in fact serve to physicaly lik
enhancer-bound activators with promoter-bound GTFs.
Activators have been shown to interact with TFIID (the biochemical fraction
containing TBP and its associated TAFs; Stringer et alI990), various TBP
associated factors (TAFs; Goodrich et al, 1993; Weinzierl et al, 1993), TFIIB
(Roberts et al, 1993; Choy et al, 1993) and TFIIH (Xao et al, 1994). In some
instances, these interactions have b en shown to increase the rate and/or extent of
PIC assembly, resulting in increased levels of transcription (Lin and Green, 1991;
Lieberman and Berk, 1994). However, these experiments have utiled in vitro
transcription reactions carried out with partialy puried or recombinant
transcription factors and naked DNA templates. In this synthetic situation, the
DNA template is completely accessible to the proteins with which it is incubated.
In contrast, DNA in vivo is tightly associated with cellular proteins to form a
compacted, proteinaceous chromatin fiber in which the DNA heli is rather
inaccessible. Careful experimentation has verifed that the compaction of DNA
into chromatin can impede the transcription process; in vitro, transcription from
chromatin templates is markedly decreased when compared to transcription from
naked DNA templates (Tsuda et al, 1986; Workman and Roeder, 1987; Lorch et
, 1987). Furthermore, this chromatin-mediated transcriptional repression can
be overcome by activator proteins, suggesting that in addition to the so-caled
true" activation described above, activators may also elevate levels of gene
expression by servng as "anti-repressors" of chromatin structure (reviewed in
Paranjape et al, 1994).
Chromatin structure
The evolutionary advantage aforded the eukaryotic cell by the compaction
of its genome into chromatin is evidenced by the rigid conservation of the
structural components of chromatin. The histone proteins, which comprise the
nucleosome core (see below) are among the most highly conserved proteins known;
the gene encodig histone H4 is over 98% conserved between cows and peas
(Wolfe, 1992). One obvious advantage to a compact chromatin structure is that a
large amount of DNA can fit into a very smal area. For example, the 3. bilon
basepais of the human genome, equivalent to over two meters of DNA strand, is
somehow packaged into a nucleus only 10 J.m, or 10. meters, in size (Wolfe
1995). On the other hand, the formation of a compact chromatin structure is
liely to occlude many of the protein-DNA interactions which, as described above,
are required for proper transcriptional initiation.
The priary level of chromatin structure in vivo is the nucleosome. A
nucleosome consists of 145 bp of DNA wrapped approxiately twice around a core
of eight histone proteins (two copies each of his tones H2A, H2B , H3 and H4) to
form a globular structure This structure, aptly described as "beads-on-a-string
is readiy visible under the electron microscope (EM) when the chromatin fiber is
extended by low salt treatment. Interactions between adjacent nucleosomes
results in stil further compaction of the genome as the 10 nm "bead-on-a-string
structure folds into a thicker 30 nm fiber. The formation of higher order chromatin
structures is likely to further occlude reguatory proteins from the DNA.
That chromatin structure plays a role in transcriptional regulation has
been well established (reviewed in Paranjape et al, 1994). Early experiments in
yeast found that misexpression of the genes encoding the core histone proteins
could markedly alter gene expression (Clark-Adams et al, 1988; Han and
Grunstein, 1988). Furthermore, in some cases these alterations in gene
expression were shown to be accompanied by changes in the chromatin structure of
the genes in question (Norris et al, 1988). Careful controls utiling
transcriptionaly defective reporters have veried that these changes in chromatin
architecture at activated genes are not due to the process of transcription itself
(Hirschhorn et al, 1992), leaving unchalenged the intriguing possibilty that the
chromatin alterations are required for (although not necessarily the cause of) gene
activation.
The problems posed to transcription by a compacted chromatin
conformation are obvious. For example, the formation of a nucleosome directly
over a TATA element could stericaly impede TBP bindig if the histone-DNA
contact withi the nucleosome core precluded the necessary TBp.TATA box
interactions. Indeed, nucleosomes have been shown to inhibit transcription
initiation either by blocking access of the general transcription machinery to
promoter sequences or by hinderig the binding of upstream activator proteins in
vitro (reviewed in Workman and Buchman, 1993). Evidence for nucleosome
repression of transcription has been found in vivo as well. In Saccharomyces
cerevisiae, nucleosomes located over the UAS of the PH05 gene under repressing
conditions were found to be altered upon gene induction and these alterations are
not dependent on transcription of PH05 (Aler et al, 1986). In contrast, the UAS
region of the divergently transcribed GALl and GALlO genes (see below) was
found to be constitutively nucleosome-free whie nucleosomes positioned over
promoter elements seem to be involved in transcriptional reguation (Fedor and
Kornberg, 1989; Axelrod et al, 1993; see below). Clearly the regulation of gene
expression by chromatin, like the other regulatory mechanisms discussed already,
are gene-specifc. Advances in the characterization of chromatin structures in
geneticaly amenable systems lie Saccharomyces cerevisiae has alowed
researchers to begi to elucidate the mechanisms involved in chromatin-mediated
transcriptional reguation. These studies have uncovered a number of proteins
and biochemical activities , distinct from those aleady discussed, which appear to
regulate gene expression at the level of chromatin structure.
In addition to interfering with transcription, the tight association of DNA
with histones and non-histone proteins in vivo is liely to inhibit other DNA-
mediat d cellular processes. Possible examples include recombination
replication and DNA repair. A number of distinct multisubunit complexes that
posses chromatin disruption activity have recently been identifed and mounting
evidence suggests these complexes may be involved in mediating these other
DNA-mediated cellular processes in the context of a repressive chromatin
structure (reviewed in Peterson , 1996). The SWIISNF complex of the buddig
yeast Saccharomyces cerevisiae appears to represent the yeast homologue of a
widely conserved complex which reguates transcriptional activation. This
complex is the focus of the research presented in this dissertation.
The identification of the SW/SNF complex
The identifcation of genes that encode subunits of the SWIISNF complex
resulted from the convergence of two independent genetic screens in S. cerevisiae:
one for products involved in the expression of the HO gene (SWItch genes), and the
other for gene products involved in SUC2 expression (Sucrose Non-Fermenter
genes). In addition to a number of genes specifcaly involved in HO expression
the former screen identifed mutations in three genes (SVV 1 , SWI2 and SWI3)
which were requied not only for the expression of HO, but also for the expression
of a number of other yeast genes (peterson and Herskowitz, 1992; Stern et al
1984). Likewise, a subset of the genes identifed in the SUC2 screen (SNF2
SNF5 and SNF6) seemed to playa global role in transcriptional activation rather
than a specifc role in SUC2 expression (Neigeborn and Carlson , 1984; reviewed in
Winston and Carlson, 1992). The functionaly related SWI and SNF gene sets
were found to overlap at the molecular level when cloning and sequencing revealed
that SNF2 and SWI2 were the same gene (Laurent et al, 1991).
Strikingly, most of the SWI/SNF-dependent genes are inducible, i. , the
expression is tightly reguated by the growth conditions and developmental state
of the cell. Furthermore, the reguation of many of these genes involves a known
gene-specifc transcriptional activator protein. These data suggested that the
SWIISNF gene products might function as global activators of transcription by
modulating the activity of activator proteins. In fact, a number of transcriptional
activators were found to require SWI SNF genes in order to function in yeast, such
as GAL4 and LexA fusion proteins that contain the activation domai of GAL4 or
the activation domai of the Drosophila activater bicoid (peterson and
Herskowitz , 1992; Laurent and Carlson , 1992). Of particular interest was the
SWI- dependence of the Drosophila fushi tarazu (ftz) protein and the mammalan
glucocorticoid (GR) and estrogen (ER) receptors (Y oshiaga et al, 1992); the SWI-
dependence of these heterologous activators strongly suggested that SWIISNF
function is conserved across evolution.
Since deletion of the SWIl, SWI2, SWI3, SNF5 and SNF6 genes
independently or in various combinations resulted in identical phenotypes, and
since these five genes were required for the expression of an identical set of yeast
genes , i seemed liely that these products functioned together, perhaps in a
complex. The Peterson and Kornberg laboratories have independently puried
this complex and in so doing have verifed that the five SWIISNF gene products
isolated geneticaly' do exist in a large multi-component complex in vivo (Cains et
al, 1994; Peterson et al, 1994). In addition to the subunits encoded by these five
known genes, this 2 MDa assembly contais six additional polypeptides (see
below).
SWISNF function in vivo
A clue as to how the SWIISNF gene products function as global activators of
gene expression came from suppressor analyses of swi/snfmutants. In these
studies, mutations in genes that encode chromatin components were found to
suppress the transcriptional defects caused by the loss of SWI SNF genes
(reviewed in Winston and Carlson, 1992; Wolfe, 1994; Peterson and Tamkun
1995). These suppressors restored the abilty of swi mutants to properly express
SWIISNF-dependent genes , includig HO and SUC2 and thereby conferred a SWI-
INdependent (SIN) phenotype. Mutations in HHTI or HHT2 (encodig histone
H3) and HHFI or HHF2 (encodig histone H4) as well as in the SINI gene
(encodig an HMG I-lie protein which is thought to be a non-histone chromatin
component) were found to aleviate the growth and transcriptional defects of swil
swi2 and swi3 mutants (Kuger and Herskowitz, 1991; Krger et al, 1995). In
additioI?' deletion of one of the two HTAl-HTBl gene clusters (encoding histones
H2A and H2B; Hirschhorn et al, 1992) or mutations in HHTI (prelich and
Winston , 1993) were able to suppress the defects in SUC2 expression of
swi2/ snf2, snl5 or snl6 mutants. These genetic interactions suggest that the
SWI/SNF gene products function to activate transcription by relieving the
transcriptional repression caused by chromatin structure in vivo.
If the SWIISNF complex functions by aleviating chromatin-mediated
transcriptional repression, why does expression of only a subset of genes depend
on its activity? For example, although many inducible genes require SWIISNF
function in order to be expressed, other genes , like GALl are only slightly afected
by the loss of SWIISNF (peterson and Herskowitz, 1992). One possibilty is that
SWIISNF activity is only required when the chromatin structure of a particular
promoter is inhibitory to transcription. For example, a strongly positioned
nucleosome located over a TATA box might impede the bindingofTBP and
thereby inhibit transcription of the adjacent gene. This model predicts that
critical promoter elements of SWIISNF-dependent genes exist within positioned
nucleosomes in vivo. The chromatin structure of two SWI- dependent genes, SUC2
and ADH2 have been analyzed. In both cases, positioned nucleosomes appear to
playa crucial role in gene expression. The expression of both genes is regulated by
carbon source; there is no ADH2 or SUC2 expression when cells are grown in
glucose. In this repressed state, nucleosomes are positioned over the TATA box
and UAS region of the SUC2 promoter (Hrschhorn et al, 1992). Upon induction
these p sitioned nucleosomes are disrupted and the gene is actively transcribed.
Nucleosome disruption does not require transcription, but does require SWIISNF
activity (Hirschhorn et al, 1992). In the case of ADH2 the promoter is also covered
by an array of positioned nucleosomes when cells are grown in glucose (Verdone et
al, 1996). These precisely positioned nucleosomes cover the RNA initiation sites
and the TATA box of the ADH2 gene, and are destabilzed upon gene induction. It
is not known whether the destabilation of these nucleosomes requires SWI/SNF
activity. Ifso , the notion that SWIISNF function involves chromatin disruption 
the vicinity ofnucleosomal protein binding sites becomes even stronger.
It is unlely that the presence of positioned nucleosomes is the sole
determinant ofSWIISNF-dependence, because a number of known SWI/SNF-
independent genes contai positioned nucleosomes over or near crucial promoter
elements. For example, the SWIISNF -independent PH05 promoter has a precise
nucleosome structure, including a nucleosome positioned over the TATA box and
UAS2 (one of two binding sites for the transcriptional activator PH04; Almer et
, 1986). Similarly, nucleosomes are precisely positioned over the divergent
GALl lOpromoter such that the GALlO TATA box and the GALl transcription
start site are nucleosomal (Fedor et al, 1988; Fedor and Kornberg, 1989). In these
two cases , gene expression is not strongly dependent on SWIISNF activity, despite
the presence of these positioned nucleosomes (peterson and Herskowitz, 1992).
Thus , SWIISNF -dependent genes may have a more specifc chromatin architecture
or other intrinsic properties which render gene expression dependent on SWI/SNF
activity:: In the studies described in this dissertation, we have utilzed the well
characterized GAL regulatory system (see below) to directly test this hypothesis.
Biochemical properties of the SWISNF complex
Two groups have puried the 2 MDa SWIISNF complex from S. cerevisiae
(Cairns et al, 1994; Cote et al, 1994). In addition to the subunits encoded by the
five genes isolated geneticaly, SWIl, SWI2/ SNF2, SWI3, SNF5 and SNF6 the
complex contains six additional polypeptides (see Table 1-1). One of these,
SNFll , was isolated in a two-hybrid screen for proteins that interact with the
SWI2/SNF2 protein (Treich , et al, 1995). Another subunit, ANCl , was originaly
isolated in a genetic screen for proteins involved in actin cytoskeletal function
(Welch et al, 1993). In addition to being a component of the SWI/SNF complex, the
ANC 1 protein is a subunit of the yeast TFIIF (Henry et al, 1994) and TFIID
(Cairns et al, 1996c) complexes. The 73 kDa subunit , SWP73 , has recently been
cloned and sequenced; deletions of and some mutations in the gene encoding this
protein result in transcription defects similar to those seen in other swi/ snf
mutants (Cairns et al, 1996a). The genes encoding the other three subunits
SWP82, SWP6l and SWP59 have not yet been reported.
The sequence of the SWI2/SNF2 gene , encoding the largest subunit of the
complex, contains seven sequence motifs that are characteristic of members of the
DEADIH superfamily of nucleic acid-stimulated ATPases and helicases (Carlson
and La rent, 1994). Therefore, it is not surprising that one of the biochemical
properties displayed by the SWIISNF complex in vitro is a DNA-stimulated
ATPase activity (Cote et al, 1994). Neither the SWI2/SNF2 protein alone, nor the
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pured SWI/SNF complex has detectable DNA helicase or DNA trackig activity
in vitro (Cote et al, 1994; Laurent et al, 1993; Quinn et al, 1996). As with other
members of the DEAD/H superfamily of ATPases, the ATPase activity of the
SWIISNF complex requires a nucleic acid cofactor (Cote et al, 1994; Cairns et al
1994). In particular, the ATPase activity of the complex is stimulated over 30-fold
by double-stranded, single-stranded or nucleosomal DNA, but not by RNA (Cote
et al, 1994). Interestingly, the presence of synthetic four way junction (4WJ) DNA
stimulates the ATPase activity of the complex to levels similar to those seen in
the presence of plasmid DNA (Quinn et al, 1996).
The ATPase activity of the SWIISNF complex is crucial to its function; 
mutation in the putative nucleotide bindig loop of SWI2 obliterates the ATPase
activity of the complex in vitro and yeast strains carryig such mutant aleles of
SWI2 display the growth and transcriptional defects of a swi2 deletion mutant
(Laurent et al, 1993; Khuvari et al, 1993). Together with the genetic suppression
data (see above), these results suggest that the SWIISNF complex might use the
energy of ATP hydrolysis to disrupt chromatin structure.
Consistent with this view, Cote et al (1994) have shown that purifed
SWIISNF is capable of disrupting the rotational positioning of DNA within a
mononucleosome in an ATP-dependent manner. Furthermore , this disruption of
rotational positioning coincides with an increased afnity of the GAL4-
activator for a nucleosomal bindig site. In fact , the afity of GAL4-AH for a
nucleosomal site in the presence of SWIISNF and ATP is only about three-fold
lower than for naked DNA. Like the disruption of rotational positioning, the
abilty of the SWIISNF complex to modulate activator bindig in this in vitro
assay is completely dependent on ATP hydrolysis (Cote et al, 1994).
These experiments suggest that the SWIISNF complex is able to use the
energy of ATP hydrolysis to modulate transcription factor binding to nucleosomal
templates, although the biochemical mechanism by which this occurs is as yet
unknown.
Other chromatin remodeling complexes
Since the cloning of the SWI2/SNF2 gene, a number of genes have been
identifed that contai ATPase domains which are more homol()gous to that of the
SWI2/SNF2 protein than to other members of the nucleic acid-stimulated ATPase
and helicase family (Carlson and Laurent, 1994). These genes have recently been
analyzed phylogeneticaly and arranged into eight subfamiles which appear to
represent functionaly and evolutionarily distinct classes of proteins (Eisen et al,
1995).
The SWI2/SNF2 subfamily contains S. cerevisiae SWI2/SNF2 as well as
another yeast gene which was identifed based on its homology to SWI2/ SNF2
caled ,!Hl (Laurent et al, 1992). Recently, Cairns et al (1996b) have puried a
novel 15-subunit complex from S. cerevisiae which contains the STH1 protein as
one of its subunits. In addition, this abundant complex, caled RSC (for its abilty
to Remodel the Structure of Chromatin), also contais two other SWIISNF -related
subunits: RSC6 is homologous to SWP73 and RSC8 is homologous to SWI3. Like
the SWIISNF complex, RSC complex purifed from yeast displays a DNA.
dependent ATPase activity and is able to alter nucleosome structure in vitro.
Unlie the SWI/SNF complex, however, the genes encoding the subunits of the
RSC complex are essential for yeast viabilty.
Other members of the SWI2/SNF2 subfamily include the human genes
BRG 1 (Kuvari et al, 1993; Chiba et al, 1994) and hBRM (Chiba et al, 1994;
Muchardt and Yaniv, 1993) and the Drosophila gene brahma (Tamkun et al
1992). The brg1 protein was first isolated from HeLa cells as part of a multimeric
protein complex which lie RSC , has many of the same biochemical properties as
the yeast SWI/SNF complex (Kuvari et al, 1993; Kwon et al, 1994; Cains et al
1996b). hBRM is also present in a high molecular weight complex in human cells
and these two complexes are thought to represent human variants of the yeast
SWIISNF and RSC complexes (Wang et al, 1996). It has further been speculated
that the brahma protein is the catalytic subunit of the Drosophila version of the
SWIISNF complex as brahma can be isolated in a high molecular weight complex
with the product of the SNR 1 gene, a homologue of the yeast SNF5 (Dingwal et al,
1995; Muchardt et al, 1995). Domain swapping experiments suggest that the
membe:s of the SWI2/SNF2 subfamily function in ways similar to that of the
SWI2/SNF2 protein. In these experiments , the ATPase domain of SWI2/SNF2
was replaced with the corresponding ATPase domai of either brg1 , hBRM or
8TH!. In al cases the chimeric proteins were able to restore proper growth and
transcriptional function in a swi2 mutant (Laurent et al, 1993; Khuvari et al,
1993; Elfing et al, 1994). In contrast, replacement of the ATPase domai of
SWI2/SNF2 with that of ISWI (a member of a distinct subfamily; see below) was
not able to complement a swi2 mutant (Elfring et al, 1994).
The subfamily which is most closely related to the SWI2/SNF2 subfamily
includes the human hSNF2L gene and the Drosophila ISWI gene (this subfamily
is referred to as the hSNF2L subfamily). These genes cannot complement the
transcriptional defects of a swi2- strain in domain swap experiments , suggesting
their roles are functionaly distinct from that of SWI2/ SNF2 (Elfring et al, 1994;
Okabe et al, 1992). However, recent evidence has suggested that the members of
this subfamily may also playa role in chromatin remodeling. Tsukiyama and Wu
(1995) have recently reported the purifcation of an ATP-dependent nucleosome
remodelig factor (NURF) from Drosophila embryo extracts. This complex
faciltates , in an ATP-dependent manner, the disruption and redistribution of
nucleosomes by the GAGA transcription factor in vitro. The NURF complex is
composed of four subunits; the 140 kDa subunit is encoded by the ISWI gene
(Tsukiyama et al, 1995). Although clearly related to the yeast SWIISNF complex
the NURF complex has unique cofactor requirements and biochemical
characteristics which suggest that it may disrupt chromatin through a distinct
biochemical mechanism. For example unle the yeast SWIISNF complex, the
ATPase activity of NURF complex is not stimulated by the presence of double-
stranded plasmid DNA, but is stimulated five-fold in the presence of nucleosomal
DNA (Tsukiyama and Wu , 1995).
The Becker laboratory has also identifed an ATP-dependent chromatin
remodeling activity in Drosophila extracts (Varga-Weisz et al, 1995; Wal et al
1995). Molecular analysis of Chromatin Accessibilty Complex (CHRAC) has
identifed two of its five subunits as ISWI and topoisomerase II (topo II; Varga-
Weisz et al, In Press). The presence of ISWI in both the CHRAC and NURF
complexes lends further support to the notion that members of the SWI2/SNF2
ATPase superfamily are modular components of the cell's chromatin remodeling
machiery.
The list of proteins that belong to the SWI2/SNF2 superfamily of ATPases
is growing steadiy (Carlson and Laurent, 1994; Eisen et al, 1995). A number of
these, including the recombination genes RAD16 and RAD54, are involved in
cellular processes other than transcription. These results have led to the
speculation that numerous chromatin reconfguration machines , each drven by a
distinct SWI2/SNF2-like ATPase motor, may exist in vivo to alow distinct classes
of DNA binding proteins access to the DNA at the appropriate time (peterson
1996). Auble et al (1994) proposed that the dierent SWI2/SNF2-lie proteins
have unique functions because they are targeted to dierent protein-DNA
comple es (see Table 1-2). For example, the yeast SWIISNF complex is targeted
to DNA bound histones , RAD 16/RAD54 to repair enzymes bound to sites of DNA
damage, and MOT1 , a TBP associated factor (TAF), to TBP-bound DNA.
Famil member Preferred cofactor
SWI2/SNF2 (SW/SNF) Synthetic four-way
junctions (strand crossover)
DS or SS plasmid DNA
Nucleosomal DNA (arrays)
ISW (NURF)
MOTt
Nucleosomal DNA
TBP-DNA complex
Table 1-2. Some SW2/SNF2 ATPase family members and their preferred
nucleic acid cofactors. The cofactor requirement for each of the SWI2/SNF2-
like proteins listed has been determined and may dictate the specificity of complex
activity. DS double-stranded; SS, single-stranded
However, the dierences in cofactor requirements between some of these ATPases
(see above) may point to another explanation for their specifcity. Each enzyme
may require a unique structured DNA to stimulate its ATPase activity, which
may dictate its role in chromatin regulation; the yeast SWI2/SNF2 complex uses
DNA strand crossovers as a cofactor for its ATPase activity, NURF ATPase
activity is stimulated by nucleosomal DNA, RAD 16/RAD54 ATPase activities
may require damaged DNA as a cofactor and MOT 1 might recognze the bent
DNA structure formed upon TBP bindig to DNA. Cofactor specifcity would liit
the catalytic activity of each complex to the appropriate site in the genome.
Testing these hypotheses awaits the purication of these distinct SWI2/SNF2-
like ATPase complexes.
The identifcation of multiple chromatin remodelig complexes and the
apparent conservation of these complexes from yeasts to mammals underscores
the importance of this level of transcriptional regulation. In order to begi a
comprehensive analysis of the role of one chromatin remodeling complex (the yeast
SWIISNF complex) in transcriptional reguation, we utilzed the well
characterized GAL gene system of S. cerevisiae.
:2'
The GALl, 10 promoter
The UAS region which controls expression of the divergently expressed
GALl and GALlO genes of S. cerevisia has been well characteried at a molecular
level (West et al, 1984). This region contains four binding sites for the
transcriptional activator GAL4 as well as a site for the abundant cellular protein
GRF2 (Fedor et al, 1988; Chasman et al, 1990). Nucleosome mapping
experiments have clearly demonstrated that this region adopts a precise
- -
chromatin architecture in vivo: using indiect end-labelig, Fedor and Kornberg
(1989) have found that the 150 bp region including and immediately surroundig
the four GAL4 binding sites is nucleosome-free under al growth conditions (See
Figure 1-2). This nucleosome-free region is flanked by precisely positioned
nucleosomes, one between the TATA element and transcription start site of the
GALl gene and the other in the region encompassing the GALlO TATA element.
These strongly positioned nucleosomes serve as a boundary between the
constitutively nucleosome-free GAL4 binding sequences and two surrounding
nucleosome arrays (see Figure 1-2). This architecture is believed to be dependent
upon the protein GRF2 , which recognzes a DNA sequence overlapping sites 1 and
2 of the GALl, 10 UAS (Fedor et al, 1988) and may be involved in setting up and/or
maitaing the nucleosome structure of this region.
Peterson et al have found that transcriptional activation by GAL4 on a
LacZ reporter gene whose expression is drven by the GALl, 10 UAS region is
SWIISNF-independent, i. e. in a swi1!1 strain, GAL4 can activate the same high
levels of transcription as it does in a SWI+ strain. Derivatives of this reporter
however, display varyig SWIISNF -dependencies (Craig L. Peterson and Ira
Herskowitz , unpublished observations), suggesting that the determinants of
GALlO GALl
Figure 1-2. The GALl, lO promoter of Saccharomyces cerevisiae.
Schematic representation of the divergent GALl , 10 promoter demonstrating
the nucleosome-free GAL4 binding sites (shaded boxes) and the precisely
positioned nucleosomes (ovals). Figure is adapted from Fedor and Kornberg,
1989 and is not drawn to scale.
SWI/SNF dependent gene expression lie within the promoter region itself.
Utilzing the GAL reguatory system described below, we set out to identif these
determinants.
The galactose utilization pathway of S. cerevisiae
There are nine genes that are necessary for yeast cells to properly utilze
galactose as a carbon source (reviewed in Johnston , 1987 and Lohr et al, 1995).
The structural genes GALl (encoding a kiase), GAL2 (encoding a permease),
GAL 7 (encoding a transferase), GALlO (encoding an epimerase), MELI (encoding a
galactosidase) and GAL5 (encoding a mutase) alow the ce to take up galactose
from its surroundings and process it into glucose- phosphate, a substrate for
glycolysis. The expression of these genes is entirely restricted to those instances
when galactose is present in the media and glucose, the preferred carbon source , is
absent. This tight regulation involves the products of the remainig three GAL
genes GAL4 (encoding a transcriptional activator), GALBO (encodig a
transcriptional inhibitor) and GAL3 (encodig a molecule required for rapid
induction).
In a widtype yeast cell, the GAL genes can exist in three regulatory states
dependi?g on the carbon source. When cells are grown with glucose as the sole
carbon source, expression of al of the GAL genes except GALBO is repressed.
Under these repressing conditions the genes encoding the transcriptional activator
GAL4 and the inducer molecule GAL3 are repressed by global transcription
repression mechanisms involvig the MIG 1 protein (Johnston et al, 1994). In
addition, any residual GAL4 protein present in the cell is prevented from
activating transcription of the other GAL genes by repressive mechanisms
involvig inhibitory DNA elements located near the UASGAL region of these genes
(URS element; Johnston et al, 1994).
In the absence of glucose, the global (MIG I-mediated) and specifc (URS-
mediated) repression mechanisms just described are circumvented and the
transcription state of the GAL genes now depends on the presence of the inducer
galactose. For example, when cells are grown with glycerol as the sole source of
carbon (therefore no glucose and no galactose), GAL4 protein is made and can bind
its sites in UASGAL regions. Howev , this promoter-bound GAL4 protein is
unable to activate transcription because of the presence of the inhibitor GAL80.
GAL80 binds to and masks the C-terminal transactivation domain of GAL4 (Ma
and Ptashne, 1987b; Lue et al, 1987), thereby inhibiting its abilty to activate the
transcription of downstream genes.
On the other hand, when cells are grown in the absence of glucose (therefore
no glucose repression mechanisms are activated) and in the presence of galactose
the GALl, GAL2, GAL7, GALlO andMELl genes are induced 100 to 1000-fold
within ~inutes. The abilty of galactose to induce this robust expression requires
the product of the GAL3 gene, which is thought to interact with GAL80 in such a
way as to inhibit its abilty to interact with the GAL4 activation domain (Suzuki-
Fujimoto et al, 1996). The unmasked, UAS-bound GAL4 is therefore able to
induce high levels of expression of al the UASGAL-containg genes. Unle the
signcant induction of expression seen for the other GAL genes (see above), GAL5
GAL3 and GALBO expression are induced only 3- 10-fold (reviewed in Lohr et al
1995). This varabilty in GAL4 induction may reflect the number and intrinsic
effectiveness of the GAL4 binding sites within individual UASGAL regions;
endogenous and consensus GAL4 bindig sequences have been found to dier in
GAL4 binding afnity in vitro (Kang et al, 1993, Vashee et al, 1993) and in vivo
(Giniger and Ptashne, 1988).
GAL4 transcriptional activation has been extensively characterized. The
varous UASGAL regions contain from one (in the case of the GALBO, GAL3 and
MELl) to four (in the case of the divergently transcribed GALl and GALlO genes;
see above) copies of the GAL4 bindig site. These bindig elements together
defie a consensus GAL4 bindig sequence , 5' - CGG A(C/G)G AC(AI) GTC
(G/C)TC CG - 3' , and a synthetic DNA that diers from this consensus at only two
positions (5' - CGGAAGACTCTCCTCCG - 3') has been shown to bind GAL4
protein in vivo (Giniger et al, 1985; this study) and in vitro (Carey et al, 1989) with
high afty. Consensus or endogenous GAL4 bindig sites , either singly or in
combination, are able to confer galactose-dependent expression onto heterologous
genes in vivo (West et al, 1984; Giniger et al, 1985; and for example Martin et al
I.e
1990). In general, increased copy number correlates with increased levels of
transcriptional activation and cooperativity is thought to playa signcant role in
GAL4 activity.
Since GAL4-responsive promoters which require SWI/SNF activity have
been identifed (see previous section) and because the galactose utilzation
pathway is so well characterized, we chose the GAL system of Saccharomyces
cerevisiae to investigate the relationship between transcriptional activation, the
SWIISNF complex and chromatin structure in vivo. In particular, we attempted to
determine: 1) which elements , if any, of a GAL gene promoter dictate SWIISNF-
dependence, 2) which domais , if any, of the transcriptional activator protein
GAL4 are involved in SWIISNF regulation, and 3) if any endogenous SWI/SNF-
dependent , GAL4-responsive genes exist in Saccharomyces cerevisiae. The results
of these lines of inquiry are detaied in the following chapters.
CHATER II
MATERIALS AND METHODS
Strain growth and maintenance
Yeast strais were grown in YEP medium (10 g/L yeast extract and 20
g/L peptone) supplemented with 20 mg/L adenine and containing as a carbon
source either 2% glucose or 2% galactose with 0.5 % sucrose. To select growth
of transformed yeast strais , cells were grown in minimal medium (6.7 g/L
yeast nitrogen base without amino acids) supplemented with the appropriate
amino acids and as a carbon source either 2% glucose or 2% galactose with
5% sucrose. YEPD and YEPGal plates were made as described above and
contained 20 g/L agar. Where appropriate, antimycin was added to a final
concentration of 1 J.g/J..
Liquid B-galactosidase assays
13-galactosidase activity of strais harboring LacZ reporter constructs
was monitored by liquid 13-galactosidase assay as described (Stern et al,
1984), Strais were grown in the appropriate medium to an ODeoo of 0.
One ml of this log phase culture was harvested by centrigation and the
pellet was washed in 1 ml ofZ Buffer (8.53 g/L NazHP04, 5.5 g/L NaHzP04,
75 g/L KCl , 0.246 g/L MgS04). Washed pellet was resuspended in 150 J. of
Z Bufer and cells were treated with 50 J. chloroform and 20 J. of 0. 1 % SDS.
Afer 30 seconds of vigorous vortexig, 700 J. of 0. 1 mg/ml ONPG, 2. 7 J.mlB-
mercaptoethanol was added and the sample was mixed by inversion.
Samples were incubated at 30 C until a yellow color was visible. Reactions
were stopped with 500 J.IM Na2C03. The absorbance (420 nm) of each
sample was determined via spectrophotometry and Mier Units of 13-
galactosidase activity was determined with the followig formula:
Units = (1000 X At20) I (ODsoo X time X volume).
Filter f3-galactosidase assays
Yeast cells were grown overnight on fiter paper (Watman 50) placed
over the appropriate agar medium. In a sterile petri dish , a second fiter
paper (Watman 3) was soaked in 0.03% X-gal (prepared from a stock of 
Gal in diethyl formamide) in Z Buffer (8.53 glL N a2HP0 , 5.5 g/L
NaH2P0 , 0.75 g/L KCl, 0.246 g/L MgS0 , 2.7 J./ml13-mercaptoethanol).
Yeast cells were permeabiled on the Whatman 50 fiter by imersion in
liquid nitrogen for thirty seconds and the frozen fiter was placed on top of the
gal soaked fiter. Care was taken to remove any air from between the two
fiters and plates were incubated at 37 C until a blue color became visible.
34 .
Nuclei preparation
Nuclei were prepared essentialy as described (Shimuzu et al, 1991).
Briefly, a one liter culture was grown in the appropriate medium to an ODsoo
ofO. L4. Cells were harvested by centrifgation and washed in S Bufer (1.4
M sorbitol, 40 mM HEPES pH 7. , 0. 5 mM MgCb, 10 mM 
mercaptoethanol, 1 mM PMSF). Mter washing, cells were resuspended in S
Buffer and incubated for ten minutes at 30 C. Cells were collected by
centriugation and resuspended in a volume of S Buffer equal to four times
the weight of the pellet. Cells were digested with 1 ml of 10 mg/mllOOT
Zymolyase (Seikagaku Corporation) for 45 minutes at 30 C. Digestion was
monitored under the microscope and was considered complete when ::90% of
the cells burst upon suspension in 0. 1% SDS. Digestion was stopped by
diution with S Buffer lackig -mercaptoethanol.
Spheroplasts were washed twice in S buffer lacking 
-mercaptoethanol
and disrupted by four passes through a Yamato LS-21 homogenizer (100 rpm)
in F Bufer (18% w/v Ficoll 400 , 20 mM PIPES pH 6. , 0.5 mM MgCh, ImM
PMSF). Disrupted spheroplasts were carefuly layered on top of GF Buffer
(20% w/v glycerol, 7% w/v Ficoll400, 20 mM PIPES pH 6. , 0.5 mM MgCh,
1mM PMSF) and subjected to high speed centrifugation. The resulting pellet
was completely resuspended in F Buffer by vortexing for five minutes at 4
Cellular debris was collected by low speed centrifgation and discarded.
Nuclei were isolated from the supernatant by high speed centriugation.
Nuclear pellet was resuspended in D buffer (10mM HEPES, pH 7. , 0.5 mM
MgClz, 0.05 mM CaClz) to make approximately 5 X cell equivalents/ml.
These nuclei were frozen in liquid nitrogen in and stored at -
End-labelling of oligonucleotides
End-labelled oligonucleotides were prepared for use in the in vivo
footprinting assay and the high resolution nucleosome mapping experiments.
100 ng of oligonucleotide was labelled in a 25 J. reaction containing 70 mM
Tris-HCl pH 7. , 10 mM MgClz, 5 mM dithiothreitol and 200 J.Ci ATP
(Amersham; 6000 Ci/mmol). Ten units of T4 polynucleotide kinase (New
England BioLabs) was added and the entire reaction was incubated at 37
for 10-30 minutes. Labelled oligonucleotides were purifed over a G-
Sephadex (pharmacia) spin column and incorporation oflabel measured on a
scintilation counter. The specifc activity of probes prepared using this
protocol ranged between 5- 10 X 10 cpm/J.g.
Internal labelling of DNA fragments
Body labelled DNA probes were prepared for use in indirect end-
labeJ.g analyses. Approximately 0. 1 J.g of agarose gel puried DNA
fragment was incubated with random primers and heated to 100 C for two
minutes, followed by a brief coolig on ice. Random Priming Bufer (2.
stock: 500 mM HEPES pH 6.6, 125 mM Tris pH 8. , 12.5 mM MgC12 , 28 mM
13-mercaptoethanol, 0.5 mM dTTP , 0.5 mM dGTP , 0.5 mM dATP), 100 J.Ci 
dCTP (Amersham , 6000 Ci/mmol) and 5- 10 units DNA polymerase I
Klenow fragment (New England BioLabs) were then added and the entire
reaction was incubated at room temperature for one hour. Labelled DNA was
puried over a G-25 Sephadex (pharmacia) spin column and incorporation of
label measured in a scintilation counter.
In vivo footprinting
A 200 ml or 100 ml yeast culture was grown in the appropriate medium
to an OD6oo of 0.75 (minial media) or 1.5-2 (rich media), respectively. Intact
cells were treated with dimethyl sulate and the methylated DNA was
isolated essentialy as described (Giniger et al, 1985), except fial pellets
were dissolved in water and quantitated on a spectrophotometer. DNA
samples were then digested with HaeIII and analyzed via a cyclic primer
extension reaction (Axelrod and Majors , 1989) using a labelled
oligonucleotide. Primer extension products were extracted with
chloroform:isoamyl alcohol (24: 1), precipitated and electrophoresed on a 
denaf&rig gel. The gel was dried and exposed to fim for 12-48 hours. As a
control for spurious primer extension products, DNA was also prepared from a
strain that was not treated with DMS. Footprinting at the widtype GALl, 10
UAS was analyzed using an oligonucleotide with the followig sequence: 5' -
GAG CCC CAT TAT CTT AGC - 3'. This oligonucleotide anneals to a
sequence located 60 bp upstream of GAL4 binding site 1. Footprinting at the
integrated GALl, 10 UAS derivatives was analyzed using an oligonucleotide
with the followig sequence: 5' - CCG GCT CGT ATG TTG TGT GG - 3' . This
oligonucleotide anneals to the unique pUC sequences located upstream of the
GAL4 binding sites in these reporters. Footprinting at integrated GALl, 10
UAS derivatives contaiing the nucleosome positioning element (NPE) was
analyzed using an oligonucleotides with the following sequence: 5' - CGG TTA
GTA CTT AAT TCC - 3' (which anneals to basepais 159 through 176 of the
NPE element; numbering of Meersseman et al, 1991) or 5' - CCG GTT CTC
GTC CGA TCA CCG - 3' (which anneals to basepais 118 through 137 of the
NPE element; numbering of Meersseman et al, 1991).
Indirect end-labelling
Nuclei were prepared as described above. To prepare Free DNA, 80
10% SDS and 30 20 mg/ml Proteinase K were added to a 1 ml alquot of
nucl i (approxiately 5 X 10 cell equivalents) and the sample incubated at
C for two hours. Lysed nuclei were treated with 180 5 M potassium
acetate on ice for one hour, subjected to centriugation and the supernatant
precipitated with isopropanol. This DNA sample was resuspended in water
and reprecipitated with ethanol. The resultant Free DNA was resuspended in
1 ml Buffer D2 (10 mM HEPES pH 7. , 5 mM MgCb, 2 mM CaCb). Free
DNA and nuclei samples were digested with 0 to 50 Units of MN ase for five
minutes at 37 C. MNase reactions were stopped by the addition of SDS and
Proteinase K. Samples were next treated with 5 M potassium acetate on ice
for one hour, subjected to centrifugation and the supernatant precipitated
with isopropanol. DNA was then digested with either ClaI (to map
nucleosomes at the integrated GALl , 10 UAS derivative reporters) or EcoRI
(to map nucleosomes at the endogenous GALl, 10 locus) in the presence of
RN ase. Digestions were extracted with bufered phenol and the aqueous layer
precipitated with ethanol. Final pellets were electrophoresed on a 1.5%
agarose gel overnight. DNA was transferred to a nylon membrane and blots
were probed with an internaly labelled 870 bp LacZ fragment (to map
nucleosomes at the integrated GALl, 10 UAS derivative reporters) or an
internaly labelled 550 bp fragment from the GALl gene (to map nucleosomes
at the endogenous GALl, 10 locus).
\.:
RNA isolation
A saturated yeast culture was diuted to an ODsoo of 0. 15 into 100 ml of
the appropriate medium and alowed to grow to an ODsoo of 0.6 - 0.8. Cells
were harvested by centriugation, washed in 5 ml of sterie water and
resuspended in 100 J. ofRNA Prep Buffer (0.5 M NaCl , 0.2 M Tris pH 7.
01 M EDTA, 1% SDS). Resuspended cells were added to a tube containing
100 J. of phenol/chloroform Ii so amyl alcohol (25:24:1) and approxiately 0.2 g
of glass beads. Samples were vortexed five times in thirty second intervals
with incubations on ice between pulses. An additional 150 J. RNA Prep
Bufer and 150 J.l phenol/chloroform/isoamyl alcohol was added to each
sample, followed by 15 seconds of mixig. Samples were then spun for 
minutes at room temperature in a microcentrifuge. 150 J. of the aqueous
phase was extracted with phenol/chloroform/isoamly alcohol and precipitated
with three volumes of ethanol at - C for at least one hour. RNA was
collected by centrifugation and washed with 70% ethanol before resuspension
in sterile, RNase-free water. RNA samples were quantitated on a
spectrophotometer and integrity was monitored on a 1% TBE agarose gel.
Samples were then stored at - C until needed.
,,'
Primer extension assays
Transcription levels were monitored using a modied version of a
previously described primer extension protocol (McKnght and Kigsbury,
1982). Briefly, 10-20 J.g of total yeast RNA and 1 ng of end-labelled
oligonucleotide were boiled in 1.25 M KCl, 10 mM Tris pH 8. , 1 mM EDTA
for one minute. Reactions were then incubated for 30-60 minutes at 50
The annealed oligonucleotide primer was extended with 10 Units of 
Reverse Transcriptase (promega) in the presence of 2. 5 mM deoxynucleotides
(dATP , dCTP, dGTP , dTTP), 50 mM Tris-HCl pH 8. , 5 mM MgClz, 100 J.g/ml
Actinomycin D , 10 mM DTT and 0.25 mM EDT A for 30 minutes at 42
Reactions were halted with 30 J.5 M ammonium acetate pH 7. 5 and
precipitated with 180 J.l ethanol at - C. Reaction products were collected
by centrifugation , resuspended in 8 l of loading dye (95% formamide, 20 mM
EDTA, 0.05% Bromophenol Blue , 0.05% Xylene Cyanol) and electrophoresed
on an 6% denaturing gel. Mter electrophoresis, the gel was dried and exposed
to fi. Sequences of the oligonucleotides used are listed below:
GALl 5' - GCG CTA GAA TTG AAC TCA GG - 3'
GAL2 5' - GAT TGT GCG CTT AA TGG G - 3'
GAL 3 5' - CTC TGC CCA GGA GAC CTA GCG - 3'
GAL 5; 5' - GGC ACC TTT AGA ACC CTC TGG - 3'
GAL 7 5' - GGT CTT TTA GCT CTG TGT GG - 3'
GALlO 5' - CCA ATG TAT CCA GCA CCA CC - 3'
GAL80 5' - GGG AGC TGC ATT AGG CAC GG - 3'
MEL1 5' - CCC AAC CCA TCT GTG GAG TG - 3'
CLN3 5' - CTA GCG GTA GCA TAC CTT GC - 3'
yT AFn90 5' - GGT TGT GGC TGA TGC GTG CC - 3'
Denaturing gel electrophoresis
Denaturing gels of the appropriate percentage were prepared using
National Diagnostics SequagelCI sequencing system accordig to the
manufacturer s instructions. Gel solutions were fitered immediately before
polymerization.
Preparation of yeast lysates
Yeast cultures were grown to saturation overnight, diuted to an ODsoo
of approximately 0. 15 in the appropriate medium and then alowed to grow to
an OD6ooofO.5 - 0.9. Five OD units of culture were treated with 1/10 volume of
100% trichloroacetic acid (TCA). Cells were collected by centrifugation
resuspended in cold TCA bufer (20 mM Tris pH 8.0, 50 mM NH40Ac, 2 mM
EDT A) and disrupted by vigorous mixing in the presence of glass beads.
Supernatant was transferred to a fresh tube and the beads washed with a
fresh 1:1 mixture of20% TCA: TCA Bufer. Wash buffer was added to
supernatant and samples spun for five minutes in a microfuge on the highest
setting. Pellets were washed with cold acetone, dred and resuspended in
TCA Resuspension Solution (3% SDS, 100 mM Tris, pH 11.0 , 3 mM DTT).
Finaly, samples were heated to C for five minutes, boiled for five minutes
more and then cooled briefly on ice. Insoluble debris was collected by
centriugation and supernatants were frozen at - C until use.
Western blotting
Lysates prepared from yeast strains harboring GAL4 expression
plasmids were electrophoresed on 10% SDS-containing, polyacrylamide gels
and transferred to a nitrocellulose membrane (Schleicher & Schuell) by
standard methods (Maniatis , 1989). Membranes were incubated with
agitation in a solution of 10% powdered milk (prepared in TBST; 100 mM
Tris pH 7. , 0.9% NaCl, 0. 1% Tween) for 30 minutes at room temperature to
block non-specifc bindig sites on the membrane. Following two ten second
rinses in TBST, the membrane was incubated with an antibody directed
against the DNA binding domain of GAL4 (a-Gal4 DBD; Santa Cruz) that
had been diuted 1:1000 in 2% milklTBST. Best results were obtaied when
this incubation was alowed to continue for twelve hours with agitation. Afer
washing, the membrane was incubated for 45 minutes with goat anti-mouse
secondary antibody that had been diuted 1:10 000 in 2% milkITBST. Finaly,
the membrane was washed and antibody recognztion was detected with the
Lumi-GloQD chemiluminescence kit accordig to manufacturer s instructions.
Strain construction
Four sets ofisogenic yeast strains were created for the studies
described in Chapter 3 of this thesis (see Table 2-2). The four strais
composing each of these sets were derived from the yeast strais CY388
(GAL4+, SWIl+
), 
CY398 (gal4Ll, SWIl+
), 
CY399 (GAL4+, swilL1) and CY400
(gal4L1, swilL1; see Table 2- 1). These founder strains contained a reporter
construct integrated at the ura3- 52 locus. In each case, the integration
resulted in a tandem duplication of the URA3 gene (one widtype and one
ura3- 52 alele) with intervening plasmid sequences. To select for cells in
which this integrated reporter had been lost (via a genetic recombination
event, i. e. "pop-out"), each strain was passaged twice on plates containing 5-
FOA. The 5-FOA resistant strains created in this way were caled CY524
CY525 , CY526 and CY527 , respectively.
These four new strains were then used to create the four strain sets
mentioned above. In each case , a unique LacZ reporter construct was
targetted for integration at the ura3- 52 locus by digestion with ApaI. CY528
CY529, CY530 and CY531 were created by integrating the plasmid pLB7
(which contains a LacZ reporter driven by a GALl, 10 UAS derivative bearng
only two high afnity GAL4 binding sites) into CY524, CY525 , CY526 and
CY527, respectively. CY532 , CY533, CY534 and CY535 were created by
integrating the plasmid pLB8 (which contains a LacZ reporter drven by a
GALl, 10 UAS derivative bearing only two low afity GAL4 bindig sites)
into CY524, CY525 , CY526 and CY527, respectively. Similarly, strais
CY586, CY587, CY588 and CY589 were prepared by integrating the plasmid
pLB16 (which is identical to pLB8 except for the addition of a nucleosome
positioning element upstream of the GAL4 bindig sites) and strains CY594
CY595, CY596 and CY597 were prepar' ed by integrating the plasmid pLB 15
(which is identical to pLB7 except for the addition of a nucleosome positioning
element upstream of the GAL4 binding sites). The genotypes of these strains
are summarized in Table 2-2. For detais on the plasmids, see below.
Mter the strains described above were prepared, it was discovered that
in the GAL4 deletion strain of each strain set (gal4L1; CY525 , CY529, CY533
CY587 and CY595), the reporter gene had been integrated at a site other than
ura3- most liely the GALl, 10 locus. This is presumably due to the fact
that the founding GAL4 deletion strain, CY398 , did not contai an intact
ura3- 52 locus for integration.
Plasmid constructions
Plasmids pLB7 and pLB8 were constructed by inserting the 194 bp
SmaI-PvulIfragment ofpUC18 between the URAB gene and the GAL4
binding sites of the plasmids pEG44 and pEG28, respectively. Plasmid
pEG44 contains two synthetic, consensus GAL4 binding sites positioned 150
bp upstream of the GALl TATA element. These two sites are separated by
32 bp (center to center distance). Plasmid pEG28 contains GAL4 bindig
sites 3 and 4 positioned 190 bp upstream of the GALl TATA element, as they
are in the endogenous GALl, 10 locus. Sites 3 and 4 are separated by 62 bp
(center to center distance), Plasmids pLB15 andpLB16 were constructed by
inserting a 182 bp PCR fragment encoding the strong nucleosome positioning
element from the 5S RNA genes of the sea urchin Lytechinus variegatus
immediately upstream of the GAL4 binding sites in pLB7 and pLB8
respectively. This fragment was amplied from pICN5S182 (git from Jerry
Workman) using the oligonucleotides 5' - CCACGAATAACTTCCAGGG - 3'
and 5' - CCCCGAGGAATTAAGTAC - 3'
Table 2-1. Yeast strains used in this study.
CY257 MATa swiL1::LEU2 lys2-80l ade2-l0l leu2-L1l his3-L1200
ura3-L199
CY296 MATa gal4L1::LEU2 lys2-80l ade2- l0l leu2-L1l his3-L1200
ura3-L199
CY297 MATa gal4Li:LEU2 swilL1::LEU2 lys2-80l ade2- l0l leu2-L1l
his3-L1200 ura3-L199
CY340 MATa lys2-L199 ade2- l0l leu2-L1l his3-L1200 ura3-L199 trpl-
L199
CY341 MATa lys2-L199 ade2- l0l leu2-L1l his3-L1200 ura3-L199
CY348 swilL1::LEU2 gal80L1 ura3- 52 URA3::pRY171 (GAL1 10)
CY349 gal80L1 ura3- 52 URA3::pRY171 (GALl 10)
CY353 MATa lys2-80l ade2-l0l leu2-L1l his3-L1200 ura3-
URA3::pRY171 (GAL1 10)
CY366 MATa swilL1::LEU2 lys2-L1l ade2- l0l leu2-L1l his3-
L1200 ura3- 52 URA3::pRY171 (GAL1 10)
CY388 MATa lys2-80l ade2-l0l leu2-L1l his3-L1200 ura3-
URA3::pEG44 (2 hi)
CY398 MATa gal4L1:: LEU2 lys2-80l ade2- l0l leu2-L1l his3-
L1200 ura3- 52 URA3::pEG44 (2 hi)
CY399 MATa swilL1::LEU2 lys2-80l ade2- l0l leu2-L1l his3-
L1200 ura3- 52 URA3::pEG44 (2 hi)
Table 2-1, continued
CY400 MATa gal4L1.:: LEU2 swilL1::LEU2 lys2-80l ade2- l0l
leu2-L1l his3-L1200 ura3- 52 URA3::pEG44 (2 hi)
CY 401 MATa lys2-80l ade2- l0l leu2-L1l his3-L1200 ura3-
URA3::pEG28 (2lo)
CY422 MATa swi1 ::LEU2 lys2-80l ade2-l0l leu2-L1l his3-
L1200 ura3- 52 URA3::pEG28 (2lo)
Table 2-2. Yeast strains constructed in this study.
CY524 MATa lys2-80l ade2- l0lleu2-L1l his3-L1200 ura3-
CY525 MATa gal4L1::LEU2 lys2-80l ade2- l0lleu2-L1l his3-L1200
ura3-
CY526 MATa swilL1::LEU2 lys2-80l ade2- l0lleu2-L1l his3-L1200
ura3-
CY527 MATa gal4L1:: LEU2 swilL1::LEU2 lys2-80l ade2- l0lleu2-L1l
his3-L1200 ura3-
CY528
CY529
CY530
CY531
CY532
CY533
CY534
CY535
CY586
CY587
'-,
CY588
CY58
CY594
Same as CY524, but contains URA3::pLB7 (2hi-p UC)
Same as CY525, but contains URA3::pLB7 (2hi-pUC)
Same as CY526 , but contains URA3::pLB7 (2hi-pUC)
Same as CY527, but contains URA3::pLB7 (2hi-p UC)
Same as CY524 , but contains URA3::pLB8 (2lo-p UC)
Same as CY525 , but contains URA3::pLB8 (210-p UC)
Same as CY526 , but contains URA3::pLB8 (2lo-p UC)
Same as CY527 , but contains URA3::pLB8 (2lo-pUC)
Same as CY524 , but contains URA3::pLB 16 (2 lo-NPE)
Same as CY525 , but contains URA3::pLB 16 (2 lo-NPE)
Same as CY526 , but contains URA3::pLB 16 (2 lo-NPE)
Same as CY527 , but contains URA3::pLB16 (2 lo-NPE)
Same as CY524 , but contains URA3::pLB15 (2 hi-NPE)
Table 2- , continued
CY595 Same as CY525, but contains URA3::pLB 15 (2 hi-NPE)
CY596 Same as CY526 , but contains URA3::pLB15 (2 hi-NPE)
CY597 Same as CY527 , but contains URA3::pLB15 (2 hi-NPE)
CHATER III
THE YEAST SWI/SNF COMPLEX FACILITATES BINDING OF A
TRANSCRIPTIONAL ACTIVATOR TO NUCLEOSOMA SITES IN VIVO
Background
Giniger et al (1985) were the fist to demonstrate that the GAL4 protein is
capable of binding to the four recognition sites found in the GALl, 10 UAS region
in vivo. These authors also showed that GAL4 could recognze a synthetic 17 
consensus sequence in vivo and that this sequence, when linked to a heterologous
reporter gene, could confer high levels of galactose inducibilty (Giniger et al
1985). In subsequent studies, Giniger and Ptashne (1988) demonstrated that
GAL4 bindig can be cooperative in vivo; these authors also suggested that this
cooperativity might explai the phenomenon of transcriptional synergy at the
GALl, 10 locus. In addition to providing the early characterization of a genetic
system which has since become an indispensable tool for the study of eukaryotic
transcriptional regulation , these early studies served as a foundation for the
experiments described in the following pages. First, the in vivo footpriting assay
developed in this study is based on that used in these earlier studies. In addition
the GALl, 10 UAS derivatives they constructed and characterized provided a
crucial starting point for the derivative promoters studied here.
Selleck and Majors (1987) have also monitored GAL4 bindig in vivo.
These authors used a photofootprinting assay (some detais of which were also
incorporated into the assay described in this thesis) to veriy GAL4 binding to the
GALl, 10 UAS. In subsequent analyses , Axelrod et al (1993) found that GAL4
binding could induce the disruption of a repressing nucleosome located in the
GALl promoter. This data complements earlier studies on the role ofnucleosome
positioning in transcriptional reguation at the GALl, 10 locus (Fedor and
Kornberg, 1989) and suggests that in addition to interacting with targets in or
near the PIC , transcriptional activator proteins may also interact with chromatin
components.
Since the SWIISNF complex is believed to be involved in transcriptional
regulation at the level of chromatin structure (see Chapter 1), we wondered if this
complex played a role in the l'eguation of the GALl, 10 promoter. Peterson and
Herskowitz (1992) have shown that transcription of GALl is decreased 2- to 6-fold
in swi/snlmutants. Although this effect is substantialy smaler than the
SWI/SNF effects seen at other genes (ADH2 expression is decreased 10- to 20-fold
and INOI expression is decreased 30-fold; Peterson and Herskowitz , 1992), it
does suggest that SWI/SNF may be involved in reguating the GAL 1 10 promoter.
As described in Chapter 1 , biochemical experiments have shown that yeast
or human SWIISNF complex can stimulate the binding of an activator protein to a
nucleosomal binding site (Cote et al, 1994; Kwon et al, 1994). Therefore, we began
our studies of SWIISNF function at the GALl, 10 promoter by exploring its effect
r on transcriptional activation and DNA bindig by the GAL4 protein. These
experiments utilzed LacZ reporter genes whose expression was controlled by
derivatives of the GALl, 10 UAS region; these UAS derivatives dier in the
afnity of the GAL4 binding sites as well as the nucleosomal context of these
sites.
Resul ts
Isogenic SWI+ and swi- reporter strains were constructed as described 
Chapter 2 and are shown schematicaly in Figure 3- 1. Strais CY353 (SWI+ and
CY366 (swil- contain a GALl, 10 UAS reporter consisting offour GAL4 bindig
sites upstream of the LacZ gene (reporter a; Guarente et al
, 1982). Strains CY 401
(SWI+ and CY 422 (swil- contain a derivative of this reporter that contains only
two of these low afnity GAL4 binding sites (sites 3 and 4; reporter b); strains
CY532 (SWI+ and CY534 (swil- contain a version of reporter b that contais 192
bp of additional plasmid sequence 20 bp upstream of GAL4 site 3 (reporter c);
strains CY528 (SWI+ and CY530 (swil- contain a reporter which contains two
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Figure 3-1. GAL4 requires functional SWI/SNF complex to activate
transcription from two low affinity binding sites. f3-galactosidase assays
were performed on isogenic SWI+ or swi- strais harboring the integrated GALl-
LacZ UAS reporter plasmid pRY171 (a), pEG28 (b), pLB8 (c), pLB7 (d) or pLB16
(e). GAL4 binding sites are denoted by smal solid boxes; larger solid boxes
represent the DNA sequences denoted. GAL4 sites numbered 1-4 represent sites
from the GALl, 10 UAS region; GAL4 sites numbered 17 indicate synthetic,
consensus GAL4 binding sites. Strains contained plasmids that overexpressed
either the bacterial LexA protein (pEG202) or the fu length GAL4 protein
(PMA210). Numbers in parentheses show activities as a percentage of the
widtype levels. 13-galactosidase activities of al reporters were 0: 1 unit in the
absence of GAL4. Drawings are not to scale; n.
, not determined.
high afity, consensus GAL4 binding sites in place of the two low afnity sites in
reporter c (reporter d; Giniger and Ptashne
, 1988). p-galactosidase assays were
performed on these various strains to monitor GAL4 transcriptional activity in
the presence of either endogenous concentrations of GAL4 (column labeled pLEXA)
or under conditions in which GAL4 is overexpressed (column labeled pGAL4).
In the absence of functional SWIISNF complex, transcriptional activation by
GAL4 from the widtype GALl, 10 UAS region is reduced only 1.5-fold compared to
the activity in the respective widtype strai (Figure 3- , reporter a). This result
is consistent with previous studies in which it was found that 
GALl expression
was only weakly afected by 
swi/ snl mutations (peterson and Herskowitz
, 1992)
In contrast, GAL4 activity on the two low afity GAL4 binding site reporters is
SWI/SNF -dependent; transcriptional activity is I'educed 22- to 32-fold in the swil-
strain as compared to the widtype strain (Figure 3-
, I'eporters b and c). When
these two low afnity binding sites were replaced with high afity, consensus
GAL4 binding sites, transcriptional activation is only reduced 1.3-
fold in the swil-
strain as compared to the wid-type strai (Figure 3- , reporter d).
Strains harboring the two low afnity site constructs were also distinct
from those carryig the two high afnity site construct in that LacZ expression
was increased 2.5 to 3. fold when GAL4 protein was overexpressed (Figure 3-
and data not shown). The simplest interpretation of this result is that
physiological levels of GAL4 are not sufcient to fully occupy the two low afty
sites (see Giniger and Ptashne, 1988 and see below). Importantly, overexpression
of GAL4 does not overcome the SWIISNF dependence of this reporter (Figure 3-
reporters b and c) It should be noted that the swil mutation does not afect
expression of GAL4 from the overexpression plasmid (peterson and Herskowitz
1992; also see Chapter 5).
To diectly assess the abilty of GAL4 to bind its sites in the dierent
reporter strais in the presence or absence of SWIISNF, we used an in vivo DMS
footprinting assay. GAL4 protects guanine residues at each end of its 17 base-
pair recogntion site both in vivo (Giniger et al, 1985) and in vitro (Carey et al
1989). As shown in Figure 3- , these guanine residues within the four GAL4
bindig sites of the GAL 1 10 UAS are protected from DMS methylation in the
presence of GAL4 (lane 3), but are accessible to 
methylation in an isogenic gal4-
strain (lane 2). Introduction of GAL4 expression plasmids into the ga14- strai
restores protection of these guanines (lanes 6 and 8), while introduction of a
plasmid expressing the bacterial LexA protein does not (lane 7). In the absence of
SWIISNF activity, pl'otection of all four sites is retained (lane 4). Furthermore
, as
shown in Figure 3- , GAL4 also protects the guanine residues at each of the two
high afnity binding sites of reporter d in the presence (lane 4) and absence (lane
5) of SWIISNF. These results are consistent with our functional studies (Figure 3-
1) in which SWI/SNF is not required for the activity of GAL4 from either the
widtype GALl, 10 UAS or the two high afnity site reporter (Figure 3- , reporters
a and d).
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Figure 3-2. GAL4 can bind its sites in the GALl lO UAS region in the
presence or absence of SWI/SNF. In vivo DMS footprinting analysis of the
GALl, 10 UAS region was performed on strains CY341 (SWI+ GAL4+ lane 3),
CY257 (swil- GAL4+ lane 4), CY296 (SWI+ gal4- lane 2), CY296 containig
GAL4 expression plasmids (pMA210 or pSD15; lanes 6 and 8), and CY296
contaiing a LexA expression plasmid (pEG202; lane 7). Lane 1 contains a
genomic guanne sequencing ladder. Boxes to the left of the figure denote the
GAL4 binding sites of the GALl, 10 UAS and asterisks denote guanine residues
shown previously to be protected by GAL4 binding.
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Figure 3-3. SWI/SNF is required for complete occupancy of two low
affinity GAL4 binding sites in vivo. In vivo DMS footpriting was performed on
strains that harbor the two high afnity site reporter (panel A): CY529 (gal4-
SWI+ lane 3), CY528 (GAL4+ SWI+ lane 4) and CY530 (GAL4+ swil- lane 5), or
strains that harbor 'the two low afity site reporter (panel B): CY533 (gal4-
SWI+ lane 2), CY532 (GAL4+ SWI+ lane 3), CY534 (GAL4+ swil- lane 4), CY532
harboring a GAL4 expression plasmid (lane 5), and CY534 harboring a GAL4
expression plasmid (lane 6). Arrow denotes the control bands , G449 and G450 by
the numbering of Yocum et al, 1984, to which phosphorimager data was
normalzed (see Figure 3-4). As a control , GAL4 bindig in the samples shown in
Panel B , lanes 2 and 6 were analyzed for GAL4 binding at the GALl lO UAS locus
(panel C). Symbols as described in Figure 3-
:"9
Figure 3-3B shows an in vivo footprinting analysis of the two low afnity
site reporter in strains CY532 (SWI+ and CY534 (swil-
). 
We detect little
protection of the two low afity sites in our footprinting assay, even in a SWI+
strain (lane 3). As discussed above , this probably reflects the low occupancy of
these sites at physiological GAL41evels , because when GAL4 is overexpressed in
this S1iVZ+ strai protection is restored (lane 5). Overexpression of GAL4 in the
absence of a functional SWIISNF complex, however, does not restore complete
protection of either low afnity bindig site (lane 6). This is most apparent at
GAL4 site 3, where strong protection is observed in the SWI+ strai (lane 5), but
only weak protection in the swil- strain (lane 6). Quantitation of these results 
phosphorimager analysis indicates that when GAL4 is overexpressed in the
absence of SWIISNF activity, protection of the relevant guanine residue in site 3 is
decreased 40% as compared to that seen in a wildtype strain (Figure 3-4).
Because al the strains analyzed in this study contai an unaltered copy of
the endogenous GALl, 10 UAS region at its normal location in the genome (in
addition to the reporter locus integrated at the URA310cus), we were able to carry
out an important internal control. The abilty of GAL4 to bind to its sites within
the GALl, 10 locus was analyzed in the same swi- sample which showed poor
protection of the low afnity sites at the reporter locus (Figure 3- , lane 6). As
shown :i Figure 3-3C, we observed complete occupancy of the four GAL4 sites 
the endogenous GAL1 10 locus in this sample. Thus, the lack of complete
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occupancy at the two low afnity sites in this strain indicates that the SWI/SNF
complex modulates GAL4 binding in vivo.
To assess whether the chromatin structure of the GAL4 binding sites was
related to their SWI/SNF -dependence, a strong nucleosome positioning element
(NPE) was inserted diectly upstream of the two low afnity bindig sites in
strais CY532 (SWI+) and CY534 (swil-
). 
This 182 bp NPE has been shown
previously to translation aly' and rotation aly position a nucleosome in vivo in
yeast (pederson and Fidrych, 1994; see also Figure 3-8). Insertion of the NPE had
a dramatic effect on the SWIISNF dependence of GAL4 function. Whe GAL4
transcriptional activity at the original two low affnity site reporter was decreased
over 20-fold in the absence of SWI/SNF (Figure 3- , reporter b), there was less
than a 1.5-fold decrease when the nucleosome positioning element was inserted
(Figure 3- , reporter e). This effect is not simply due to insertion of foreign DNA
sequences upstream of the GAL4 binding sites because insertion of 192 bp ofpUC
plasmid sequences at an identical position did not alter the SWI/SNF dependence
of GAL4 activity (Figure 1 , reporter c).
These results suggest that the SWIISNF -dependence of GAL4 can be
modulated by nucleosome positioning. To confrm this possibilty, we analyzed
the chromatin structure of some of the reporters tested in Figure 3- 1. As shown
previously by Fedor and colleagues
, the four GAL4 binding sites at the GALl, 10
locus are located in a constitutively nucleosome-free region that is flanked by
arrays of positioned nucleosomes (Fedor and Kornberg, 1989; see also Figure 3-5).
1921 bp
1110 bp
550 bp
FreeDNA Chromatin
Figure 3-5. Nucleosome mapping of the GALl, 10 UAS region. Free DNA and
nuclei from the two low afnity site SWI+ reporter strain (CY532) were treated
with increasing amounts ofMNase and nucleosome positioning at the GALl
locus was analyzed by indiect end-labellng. MNase treatments were as follows:
1 Unit/ml, lane 1; 5 Units/ml, lanes 2 and 3; 25 Units/ml, lane 4. Schematic to the
right of each panel depicts mapped locus, black rectangles represent GAL4
binding sites , shaded boxes represent codig sequence of the indicated gene, and
shaded ovals represent the predicted position of nucleosomes. Primers used to
ampliy the probe fragment by PCR are indicated by black bars. Migration of
DNA size standards are noted to the left of each panel.
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Figure 3-6. Nucleosome mapping of the two low affinity site reporter
locus. Free DNA and nuclei from the two low afity site SWI+ reporter strain
(CY532) were treated with increasing amounts ofMNase and nucleosome
positioning at the reporter locus was analyzed by indiect end-labellng. MNase
were as follows: 0 Units/ml, lanes 1 and 7; 0.005 Units/ml, lanes 2 and 8; 0.
Units/ml, lanes 3 and 9; 0.5 Units/ml, lanes 4 and 10; 5 Units/ml, lanes 5 and 11;
50 Units/ml, lanes 6 and 12. Restriction sites used to generate the probe
fragment are indicated on the map. Symbols as described in Figure 3-
The precise nucleosome positioning of this region is believed to require the GRF2
protein, which binds to a sequence that overlaps GAL4 binding sites 1 and 2
(Fedor et al , 1988). The GALl, 10 UAS derivatives that we have analyzed in this
study (Figure 3- , reporters b-e) lack this GRF2 binding site and therefore may
not maitain nucleosome positioning in the region surrounding the GAL4 binding
sites. To test this idea directly, we analyzed the chromatin structure of the two
low afnity site reporters in the SWI+ strains CY532 (without NPE; reporter c in
Figure 3- 1) and CY586 (with NPE; reporter e in Figure 3- 1) and compared these
structures to that of the GAL 1 10 locus in the same strais.
Nuclei and free DNA were prepared from the 
SWI+ strain CY532 , which
contains the parental two low afnity site reporter (reporter c in Figure 3- 1) and
samples were analyzed by MN ase digestion and indirect end-labeling. First, we
analyzed the chromatin structure 
at the GALl locus of this strain (Figure 3-5).
Comparison of the MN ase cleavage pattern in free and chromatin DNA samples
reveals a repeating pattern ofMNase protections, each approximately 140 bp in
size and flanked by MN ase hypersensitive sites. These results are essentialy
identical to a previous study (Fedor and Kornberg, 1988) and are consistent with
an array of positioned nucleosomes downstream of the nucleosome-free GAL4
binding sites.
imilar analysis of the two low afnity site reporter locus in this same
strain yielded very dierent results (Figure 3-6). In the region upstream of the two
, \GAL4 binding sites , the MN ase digestion pattern in the chromatin sample is
similar to the pattern of digestion in the free DNA, although we do reproducibly
observe several preferred cleavage sites in free DNA that appear to be enhanced in
the chromatin sample. Importantly, the MNase cleavage sites directly upstream
and adjacent to the GAL4 bindig sites are cleaved with equal effciency in the
free and chromatin DNA samples. A region of approxiately 80 bp, which
- contains the GAL4 binding sites, is not cleaved effciently in either the free or
chromatin samples; this is due to the inherent sequence specifcity ofMNase I and
is not due to a positioned nucleosome (Fedor and Kornberg, 1988). In addition
this protected region is not flanked by hypersensitive sites. Directly downstream
: of the GAL4 binding sites, however, a 140 bp region ofMNase resistance which is
flanked by MN ase hypersensitive sites is observed, suggesting the presence of a
positioned nucleosome. The location of this putative nucleosome corresponds to
the positioned nucleosome located between the GAL4 sites and the GALl TATA
box of the endogenous GALl, 10 locus that has been identifed by others (Fedor and
Kornberg, 1988; Axelrod et al, 1993; see also Figure 3-5). Thus, although one
nucleosome appears to be positioned at the GALl, 10 UAS derivative in this strain
(reporter c), the majority ofnucleosome positioning has been lost.
Nucleosome mapping of the SWI+ strai CY528, which harbors the two high
afnity site reporter derivative (reporter d in Figure 3- 1), revealed a pattern very
similar to that seen with the two low afnity site reporter strai just described.
Specifcaly, 1) in the region upstream of the GAL4 binding sites , the MNase
digestion pattern in the chromatin sample is similar to the pattern of digestion
observed in the free DNA , 2) as expected, the GAL4 bindig sites themselves are
resistant to MNase cleavage, and 3) a protected region the size expected of a
nucleosome was observed between the GAL4 sites and the downstream GAL 1
TATA box (Figure 3-7). Together with the results presented in Figure 3-
, these
, results suggest that the removal of the presumptive nucleosome positioning
elements of the GALl, 10 UAS region (i.e. the GRF2 binding sites) can alter
nucleosome positioning over this region in vivo. In the absence of a positioned
array ofnucleosomes, these GAL4 binding sites are unlkely to reside in a
constitutively nucleosome-free region.
MNase digestions and indirect end-labeling were also used to confrm that
the NPE in strain CY586 (see Figure 3- , reporter e) positioned a nucleosome
upstream of the two low afnity GAL4 binding sites (Figure 3-8). Comparison of
. the free and chromatin DNA samples reveals an MN ase resistant region of about
50 bp (including the NPE sequences as well as the MNase-resistant GAL4
. '
inding site sequences), consistent with positioning of a nucleosome over the NPE
equence. In addition , the putative positioned nucleosome located between the
AL4 binding sites and the GALl TATA box that was detected at the GALl
ocus (Figure 3-5), at the parental two low afity site reporter (reporter c; see
'Figure 3-6), and at the two high affnity site reporter (reporter d; see Figure 3-
7) is
also detected at the NPE-containing 
reporter locus of CY586 (reporter e; see
Free DNA
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Figure 3-7. Nucleosome mapping of the two high affinity site reporter
locus. Free DNA and nuclei from the two high afnity site SWI+ reporter strain
(CY528) were treated with increasing amounts ofMNase and nucleosome
positioning at the reporter loci was analyzed by indirect end-labellng. MNase
treatment was as follows: 0 tJ/ml, lanes 1 and 6; 0.005 U/ml, lanes 2 and 7; 0.
U/ml, lane 8; 0. 5 U/ml, lanes 3 and 9; 5 U/ml, lanes 4 and 10; 50 U/ml, lanes 5 and
11. In this map, the two high afity GAL4 binding sites are depicted as open
boxes. Migration of DNA size standards are noted to the right.
2620 bp 
2170bp 
870bp 
FreeDNA Chromatin
3 4
MNase
.. 
Bam
 
CIa!
Figure 3-8. Nucleosome mapping of the two low affinity site reporter
containing a nucleosome positioning element. Free DNA and nuclei from the
NPE-contaiing, two low afnity site SWI+ reporter strain (CY586) were treated
with increasing amounts ofMNase and nucleosome positioning at the reporter
locus was analyzed by indirect end-labellng. MN ase treatment was as follows:
5 Units/ml, lanes 1 and 3; 5 Units/ml, lanes 2 and 4. Restriction sites used to
generate the probe fragment are indicated on the map accompanying each figure.
Symbols as described in Figure 3-
In results l'eported elsewhere , Burns and Peterson (1997) have used a
restriction enzyme accessibilty assay to monitor the nucleosome state of the
GAL4 bindig sites in some of the reporters described above (reporters a, c and e).
This data is in good agreement with the indirect end-labeling experiments
described above and veriy that in reporter c, the two low afity GAL4 binding
sites are nucleosomal (as evidenced by their inaccessibilty to restriction enzyme
digestion in the accessibilty assay). In this same assay, the four GAL4 binding
sites of the endogenous GALl, 10 UAS region as well as the two low affnity sites
in the NPE-containing reporter e are completely accessible to enzyme cleavage
indicating that these regions are free of nucleosomes (See Appendi B).
Discussion
The results described above suggest that the SWIISNF -dependence of a
transcriptional activator protein is not an innate feature of the activator protein
per se, but rather reflects the chromosomal context of the activator binding sites.
When the activator binding sites are encompassed in a nucleosome, as in the two
low afnity site reporter used in this study, SWIISNF function is necessary for the
activator protein to bind to and activate transcription from those sites (see Figure
, top) : On the other hand, when binding sites are nucleosome-free, as is the
case at the GALl, 10 UAS region or at the NPE-containing two low afnity site
reporter, then SWIISNF function is dispensable for GAL4 activity. In this case
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GAL4 can bind to its sites and activate transcription in the absence of SWIISNF
activity (see Figure 3- , bottom). Furthermore, SWI/SNF dependence does not
appear to correlate with the level of transcriptional activation since we have found
both weak and strong promoters whose activity is dependent upon SWIISNF (see
Figure 3- 1). Thus, based on the results presented here, we predict that the subset
of genes whose expression requires SWIISNF wi have activator bindig sites that
are encompassed in nucleosomes; genes that do not require SWIISNF wi have
such sites positioned between nucleosomes. This positioning may be determined
by DNA sequence , as in the NPE-contaiing reporter, or by abundant DNA bindig
proteins like GRF2 , as in the case of the intact GALl, 10 reporter.
Our results also require that binding site affnity be incorporated into the
defiition of SWIISNF -dependence. Whle GAL4 requires SWIISNF in order to
access low afity, nucleosomal binding sites, high afnity, nucleosomal sites are
occupied even in the absence of SWI/SNF. The abilty of higher afnity binding
sites to aleviate SWIISNF -dependence provides strong evidence that the
SWIISNF complex modulates transactivation at the level of DNA binding.
Furthermore, these results suggest that GAL4 binding to high affity
nucleosomal sites can occur in vivo via a SWIISNF independent mechanism.
These results are consistent with in vitro studies of Workman and Kingston
(1992) 'Who found that GAL4 can bind to a nucleosomal site to form a tripartite
transcription factor-histone-DNA complex.
,t"
As noted above, we detect a consistent level of GAL4 binding to the low
afnity sites in the swil- strain (Figure 3- , compare lanes 5 and 6);
phosphoriager analysis indicates site 3 may be occupied at 60% of the levels
seen in a SWI+ strain (Figure 3-4). The fact that this level of occupancy results in
negligible levels of transcription (3% of wid type levels, see Figure 3- , line b) may
indicate a role for the SWIISNF complex in transcriptional activation beyond the
modulation of activator bindig. In light of recent reports suggesting that the
SWIISNF complex associates with the RNA polymerase II holoenzyme (Wilson et
al, 1996; but see also Cairris et al, 1996b), it is interesting to consider the
possibilty that an activator-SWIISNF interaction is involved in preinitiation
complex assembly. On the other hand, our in vivo footprinting procedure does not
alow us to determine the extent to which site 3 and site 4 are simultaneously
occupied, nor can we distinguish whether the 60% occupancy in a swi/ snf strai
reflects the stable binding of GAL4 in 60% of the cells, or reflects weak, unstable
binding in 100% of the cells. Therefore, our results may support an additional role
for the SWIISNF complex in faciltating the cooperative bindig of GAL4 or in
enhancing the stabilty of GAL4 binding to low afity, nucleosomal sites iIi vivo.
Finaly, it is important to note that although the protected region identifed
(by indirect end-labelig analysis; see Figures 3- , 3- , 3-7 and 3-8) between site
four an the GALl TATAbox of al the reporters analyzed in this chapter is
consistent with a positioned nucleosome, these results may also indicate the
bindig of a sequence-specifc DNA binding protein to this region in vivo.
CHATER IV
CHAACTERIZATION OF THE ROLE OF THE GAL4 ACTIVATION DOMAN
IN SWI/SNF TARGETING
Background
The 888 residue GAL4 protein has been extensively characteried and its
modularity well documented (Brent and Ptashne, 1985; Keegan et al, 1986). The
terminall47 amino acids encode the DNA binding and dimerization activities
, " i
of the protein (Keegan et al, 1986; Carey et al, 1989). This domain functions
independently of the rest of the protein and has been used to target a diverse
array of transcription factors and activation domains to promoter regions bearing
GAL4 sequence bindig elements in vivo and in vitro (for example see Barberis et
, 1995; Chatterjee and Struhl, 1995). Two separable activation domains have
been identifed within the GAL4 protein, although it is the region of the C-
terminus between residues 768 and 881 which, is thought to be the physiologicaly
relevant transcriptional activating, region (la and Ptashne, 1987a). This domain
is the target of the inhibitor GAL80 (see above) and a number of studies have
identif d residues which appear to be crucial for transactivation (Lue et al, 1987;
Leuther et al, 1993). The volume of studies characterizing the structure and
function of the GAL4 protein has resulted in the avaiabilty of a library of GAL4
:' 
expression plasmids which encode GAL4 derivatives varying in stabilty, DNA
binding abilty and transcriptional activity.
As discussed in detai in Chapters 2 and 3, we have constructed a set of
isogenic yeast strains harboring a LacZ reporter gene whose expression is
dependent upon the presence of 1) the transcriptional activator GAL4 and 2) a
functional SWIISNF complex. In the absence of SWIISNF LacZ expression from
this two low afity site reporter is decreased over 20-fold and GAL4 binding to
one of the two low afnity sites is decreased by 40% (see Chapter 3). In the
experients described below, we have used this reporter gene and the library of
avaiable GAL4 expression plasmids to dissect the functional components of
GAL4 which playa role in the SWIISNF -dependent transcriptional activation.
Resul ts
Although GAL4 binding to the two low affnity site reporter is decreased
substantialy in the swil- strai, we do detect a consistent level of GAL4 binding
to these sites (see Chapter 3, Figure 3-3B); in fact, phosphorimager analysis
indicates site 3 may be occupied at 60% of the levels seen in a SWI+ strain
(Chapter 3 , Figure 3-4). One possible explanation for this finding is that GAL4
binding to nucleosomal sites is stabilzed by two independent pathways (Figure 4-
1). In t e fist pathway, the SWIISNF complex faciltates the interaction between
the activator and the DNA in the context of underlyig nucleosomes. In the
second, interactions between the activation domain of GAL4 and its target(s) in
SWI/SNF
...
e__e
- ..' " ... --...- ." .... .. - ' "' "". 
'I..
1 :
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Figure 4-1. Alternative models for the stabilzation of GAIA binding in vivo.
Schematic depiction of a eukaryotic promoter. Shaded boxes represent binding
sites for transcriptional activator proteins, bent arrow depicts transcription start
site , dashed circles represent nucleosomes. In pathway (1), chromatin remodel-
ing machines like the SWIISNF complex stabilze activator binding to nucleosomal
sites. In pathway (2), interactions between the activation domain ofthe activator
protein and components of the general transcription apparatus stabilze activator
binding. These models are not mutually exclusive.
. '
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the preinitiation complex is able to stabilze its binding to the sites. In order to
address this possibilty, we tested the abilty of a GAL4 derivative lackig an
activation domain (PMA424) to bind to the two low afnity site reporter in the
S"W+ yeast strai CY533.
As shown in Figure 4- , the guanine residues within the two low afity
GAL4 binding sites in this strain are protected when ful length GAL4 protein is
overexpressed (lane 2), but not when an irrelevant bacterial protein is
overexpressed (lane 4). When the GAL4 DNA binding domain alone is
overexpressed, the relevant guanines are stil protected (lane 3). Phosphorimager
analysis verifes that the protection observed for the DNA bindig domain alone is
similar to that of the full length protein (Figure 4-3). As expected, both fu length
GAL4 and the DNA binding domain alone are able to bind to al four GAL4 sites
found at the endogenous GALl, 10 locus (Figure 4-2B). These results indicate that
the GAL4 activation domain is not required in order for SWIISNF to modulate
GAL4 bindig in vivo. In the context of the model presented in Figure 4- , these
results suggest that the two pathways for stabilzing GAL4 binding to
nucleosomal sites are redundant; in the absence of either pathway, DNA binding
continues to be stabilzed by the other.
A prediction of this model is that the inactivation of both pathways would
lead to loss of GAL4 bindig to the nucleosomal sites and therefore a loss of
protection in our in vivo footprinting assay. To test this prediction, we set out to
measure the abilty of the GAL4 DNA binding domain to bind the two low afnity
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Figure 4-2. An activation domain is not required for GAL4 binding to low
affinity, nucleosomal sites in vivo. In vivo DMS footpriting was performed on
strains harborig the two low afnity site reporter and the GAL4 expression
plasmids pMA210 (panel A, lane 2; Panel B , lane 3), pMA424 (panel A, lane 3;
Panel B , lane 2) or the negative control plasmid pEG202 (panel A, lane 4; Panel B
lane 1). In Panel A protection was analyzed at the two low afnity site reporter
locus. In Panel B protection was analyzed at the endogenous GALl, 10 locus.
Lanes marked G represent genomic guanine sequencing ladders for the respective
loci. Schematics to the side of each panel depict the respective loci; open boxes
denote GAL4 binding sites and asterisks denote guanine residues shown
previously to be protected by GAL4 bindig.
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GAL4 binding sites in our reporter in the absence of functional SWI/SNF complex.
Unfortunately, many fusion proteins and protein derivatives, includig the GAL4
DNA binding domai derivative used in these studies, are notoriously unstable in
swi/ snf mutants (C. Peterson, unpublished results and Figure 4-4). In order to
overcome this setback, we set out to identify transactivation-defective GAL4
derivatives which were stable in a swi/snfmutant.
Table 4- 1 lists the GAL4 expression plasmids tested in these studies. Each
expression plasmid was transformed into the isogenic strains CY296 (SWJ+) and
CY297 (swil-
); 
in both of these strains the chromosomal GAL4 gene has been
deleted (gal4i'). GAL4levels in lysates prepared from these transform ants was
determined by Western blotting with an antibody that recognzes the DNA
bindig domain of GAL4. As shown in Figure, , ful length GAL4 protein
(PMA210) was detected in lysates from both SWI+ and swi- cells (lanes 1 and 2);
the apparent increase in GAL4levels in the swi- sample shown in Figure 4-4 is
probably not genuine as it is not seen in other experiments (data not shown and
see Figure 4- 5). Lysates prepared from SWI+ andswi- strains transformed with
the GAL4 expression plasmids pGG23 (lanes 5 and 6), pGG23 D199Y (lanes 13
and 14), pCD 14XX (lanes 11 and 12) and the control plasmid pEG202 (lanes 3 and
4) contained no detectable GAL4 protein. The absence of detectable GAL4
however. does not suggest a priori that no GAL4 protein is produced in these cells
as in some instances the GAL4 derivative is able to activate transcription of
reporter genes (for example pGG23: see Table 4- 1 and see text below).
N '
pMA210
pGG23
pGG23 D199Y
:j."' ....
pCD19XX
"'Y'
.J'
:,, ',-' '
t. 
.. .' .
It 
pMA424
;1"
pGG23
pEG202
pCP175
il-
- - ------.-.----------.--  - - - - , -
- u ,
, +
pCD14XX
A A
Figure 4-4. Western analysis ofGAL4 derivative proteins. Lysates prepared
from the yeast strains CY296 (SWI+ and CY297 (swil- transformed with the
indicated GAL4 expression plasmids were analyzed by Western blot (see Chapter
2). Numbers to the right denote the migration of protein size standards. NOTE:
The samples in lanes 9 11 and 13 were prepared from a swi- strain, contrary to
the labels in the figure. Likewise , the samples in lane 10 , 12 and 14 were
prepared from a SWI+ strain. Lanes 1 through 8 and 15 through 18 are labeled
properly.
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Only three of the GAL4 expression plasmids tested in this study produced
detectable GAL4 derivatives: lysates prepared from cells transformed with
pCD 19XX (lane 7), pMA424 (lane 9) and pCP 175 (lane 15) contained GAL4
proteins with approximate molecular weights of 43 kDa (677 amino acids), 17 kDa
(147 amino acids) and 17.5 kDa (162 amino acids), respectively. Of these, the
GAL4 derivatives produced in the pMA424 and pCP175 transform ants were
unstable in the swi- strain (lanes 10 and 16, respectively). On the other hand, the
GAL4 derivative produced in the pCD 19XX transform ant was present in the swil-
strai (lane 8), indicating it was stable in the swil- strain. This derivative
(hereafer referred to as CD19) was chosen for further analysis.
, To verify that the CD 19 protein was defective in transactivation , liquid 13-
galactosidase assays were performed. The strain CY533, which harbors the two
low afnity site reporter, was transformed with the plasmid pCD 19 and liquid 13-
galactosidase assays were performed on three individual transform ants. 
shown in Table 4- 1 (column labeled 2lo), the overexpression of full-length GAL4 in
this strain led to high levels of trans activation , however, very little activity was
seen when CD 19 was overexpressed. Interestingly, the GAL4 derivative encoded
by the plasmid pGG23, which was completely undetectable by a Western blot of a
cell lysate, was able to activate reporter gene expression to low levels (see Table 4-
1 and F gure 4- , lane 4). Western blots were used to veriy the stabilty of CD 19
in this new strain background and the results are shown in Figure 4-5. Similar to
the fuUlength GAL4 protein (lanes 1 and 2), CD 19 protein levels in the swi
ZOZD3d
:!..
XX61G;)d
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' "
c::
;'' 
i; ;'
Figure 4-5. The GAL4 derivative CD19 is stable in a swi/snfstrain. Western
analysis was performed on yeast strains CY533 (SWI+ and CY535 (swil- that
had been transformed with the GAL4 expression plasmids pMA210 (lanes 1 and
2), pCD19XX (lanes 3 and 4), or the control plasmid pEG202 (lanes 5 and 6).
These strains carry the two low afity site reporter and a deletion of the
endogenous GAL4 gene. Numbers to the right indicate migration of protein size
standards.
mutant are essentialy unchanged in the isogenic SWI+ strain (lanes 3 and 4). As
expected, lysates from strains hal'boring the control plasmid pEG202 , which
encodes a bacterial protein unrelated to GAL4, contained no detectable GAL4
protein. These results identify a CD 19 as a transcriptionaly defective yet
inherently stable GAL4 derivative. We next used this derivative to test the model
presented in Figure 4- 1 and described above.
The abilty of CD19 to bind to the GAL4 sites in the two low afnity site
reporter in the presence and absence of SWIISNF was monitored by in vivo DMS
footpriting. As shown in Figure 4-6, both CD19 and full length GAL4 protein
(M10) were able to occupy low affnity GAL4 binding sites in the presence of
SWI/SNF (panel A, lanes 3 and 4). In the swi- strain, however, neither protein was
able to fully occupy these sitescPanel A, lanes 6 and 7). In agreement with the
results presented in Chapter 3 , we observe a decrease in protection by the ful
length GAL4 protein in the swi- strain as compared to the SWI+ control. In the
experiment shown , GAL4 occupancy was decreased by over 60% (Figure 4-7). A
similar decrease (53%) was seen in CD19 binding to the site 3 (Figure 4-7).
Discussion
Workman and Kigston (1992) have shown that the transcriptional
activator GAL4 can bind to its sites in a nucleosomal DNA template to form a
tripartite DNAlstone/GAL4 complex. These results indicate that GAL4 may

Figure 4-6. The activation domain mutant CD19 is able to partially bind
nucleosomal GAL4 binding sites in the absence of swi/snf. In vivo DMS
footprinting analysis was performed on strain CY533 (gal4f1 SWI+ that had been
transformed with the GAL4 expression plasmids pMA10 (lane 2), pCD19 (lane
3) or the control plasmid pEG202 (lane 4); the same analysis was carried out on
the strain CY535 (gal4f1 swi- that had been transformed with the same plasmids
(lanes 5, 6 and 7, respectively). GAL4 binding to the two low afity site reporter
locus in these strais is shown. Lane 1 contais a genomic guanine sequencing
ladder. Symbols as described in the legend to Figure 4-
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recognize its sites in vivo even when they are encompassed in a nucleosomal
structure. The fact that overexpression of GAL4 protein in vivo leads to increased
occupancy ofnucleosomal sites may indicate that in the presence ofnucleosomes,
GAL4 binds its sites weakly and has a high dissociation rate. Increased local
concentrations of GAL4 protein can partialy compensate for this high off rate and
is demonstrated in our footprinting assay by increased protection (see Chapter 3).
Importantly, we fid that the abilty of increased GAL41evels to support
occupancy ofnucleosomal sites requires the SWIISNF complex. This result
indicates that the SWIISNF complex can further stabilze GAL4 binding, although
the mechanisms by which SWIISNF accomplishes this stabilzation remains
unclear. Based on the biochemical and genetic results summarized in Chapter 1
this stabilzation may involve alteration of histone-DNA contacts within the
underlyig nucleosome, resulting in an increased afity of GAL4 for its site (e.
decrease in the dissociation rate).
The data presented in this chapter indicate that the SWIISNF complex can
also modulate the bindig of a truncated GAL4 derivative consisting solely of the
DNA binding domai. These results indicate that the mechanism by which the
SWIISNF complex stabiles binding to nucleosomal sites does not require the
activation domai. Furthermore, these results leave unanswered the question of
how theJnere one hundred copies of the SWIISNF complex which are thought to
exist within the typical yeast cell are targeted to the sites in the genome at which
its function is required (Dingwal et al, 1994; Cote et al, 1994; Cains et al1994).
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Even in the absence of SWI/SNF complex, we detect some binding to the
nucleosomal GAL4 sites in our two low afnity site reporter. As shown in Figure
, one possible model for this result is that GAL4 bindig to nucleosomal sites
is stabilzed by at least two dierent pathways. In the first, the SWIISNF
complex modulates binding via an unknown mechanism. In the second,
interactions between the activation domain of GAL4 and its downstream targets
(the general transcription machinery) leads to more stable GAL4 binding. If this
model is correct, our previous results suggest that these two pathways are not
mutualy exclusive and that in the absence of one, the other continues to stabilze
bindig (we see substantial residual GAL4 bindig in swi/ snf mutant; see
Chapter 3). In the studies presented here , we used a GAL4 activation domai
mutant, CD19 , to test this model further.
We find that in the presence of SWIISNF , CD19 is able to bind to
nucleosomal sites as well as the ful length GAL4 protein does. If the model
presented above is correct , CD 19 binding in this case is solely the result of
SWI/SNF modulation of binding, since interactions between the bound activator
and its downstream targets are disrupted in this activation domain mutant. 
the other hand, the activation domain of the fu length protein is able to interact
with downstream targets and as a result, its bindig to nucleosomal sites is
stabilz by both SWIISNF and activator-PIC interactions. If this is true, then
one would predict that in the absence of SWIISNF, ful length protein would retai
the binding conferred by interactions between its activation domain and its
105
downstream targets; CD19 , however, would be unable to bind to the nucleosomal
sites at al as both means of stabilzation have been disrupted. This is not the
observed result. Instead, we find that CD19 is able to bind the nucleosomal sites
in our two low afnity site reporter almost as well as the ful length GAL4 protein
(Figures 4-6 and 4-7). These results suggest that the residual GAL4 binding seen
in a swi/ snf strain is not due to the stabiling effect of interactions between the
activation domain and downstream transcription machinery and that this
residual SWIISNF -independent GAL4 binding to low afity, nucleosomal binding
sites reflects intrinsic binding properties of the DNA binding domain.
.a -:i '
106
CHAPTER V
CHARACTERIZATION OF THE GAL- PHENOTYE OF swi/snfMUTANTS
Background
Yeast strains bearing mutations in genes encoding components of the
SWIISNF complex display a slow growth phenotype on all types of growth media.
This slow growth is exacerbated on media containing galactose as the sole source
of carbon as well as on media lacking inositol; on these medias swi snf mutants
cannot grow at all (Neigeborn and Carlson, 1984, Peterson, et alI992). These
phenotypes have been attributed to reduced transcription of the genes involved in
galactose and inositol utilization in swi/ snf mutants , in part because the defects
can be suppressed by the same chromatin mutations (e.g. deletion of the HTAl-
HTBI gene set) that suppress the characterized transcriptional defects in swi/snf
mutants (Hirschhorn et alI992).
In the experiments described below , an attempt was made to identify genes
in the galactose utilization pathway (GAL genes) which are dependent upon
SWI/SNF activity for expression. If the inabilty of swi/snfmutants to grow on
galactose: media is indeed due to misexpression of one of the GAL genes , we
expected to uncover an endogenous , SWIISNF-dependent, GAL4-responsive
promoter analogous to the synthetic SWIISNF -dependent two low affinity site
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reporter we have previously characterized (see Chapters 3 and 4). The GAL4
binding sites of such a gene might reside within a region of positioned
nucleosomes such that GAL4 cannot occupy the sites in the absence of SWIISNF.
The correlation of SWIISNF -dependence with the nucleosomal state of promoter
binding sites in the promoter region of an endogenous, SWIISNF- dependent GAL
gene, would provide strong support for our model.
Results
As shown in Table 5- swil- cells display a growth defect on both glucose-
and galactose-containing media. This growth defect is well documented
(Neigeborn and Carlson, 1984; Peterson et al, 1991) and is identical to that
observed in other swilsnfmutants (including swi2, swi3, snf5, snf6 and swp73).
Hirschhorn et al (1992) have shown that this growth defect is exacerbated on
galactose plates containing antimycin. In the presence of this electron transport
chain inhibitor, yeast cells are forced to rely on glycolysis to provide the energy for
cell growth, as the energy normally afforded by oxidative metabolism is disrupted.
In the experiment shown in Figure 5- , a swiL1 strain (CY257) and its isogenic
SWI+ counterpart (CY340) were streaked onto agar plates containing the drug
antimycin. While the SWI+ cells grow at similar rates on glucose-containing
(panel A)' and galactose-containing (panel B) media in the presence of antimycin
the swil- cells are unable to grow at all on galactose plates containing antimycin
(panel B). The swi- cells do grow on glucose-containing media in the presence of
108
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Growth
Media SWI+ swi-
YPD
++++
YPD + antimycin
YPGal
YPGal + antimycin
Table 5-1. Growth defects of swVsnf mutants.
Growth on the indicated media is designated by "+" symbols llo growth is
designated by " symbols.
Glucose + antimycin
GalaCtose + antimycin
":' , "
'0;
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Figure 5- 1. swVsnfmutants display growth phenotypes on antimycin-
containing media. SWI+ and swi- yeast strains were streaked onto plates
containing the drug antimycin and either glucose (Panel A) or galactose (Panel B)
as the sole carbon source. Schematics to the right indicate the genotypes of the
strains shown in the plates on the left.
''1
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antimycin (panel A). This sensitivity to antimycin under anaerobic conditions
has been used by others to define the Gal- phenotype of swil snf mutants
(Hirschhorn et al, 1992; Cairns et al, 1996a).
In order to identify the gene(s) responsible for the Gal- phenotype of the
swil- strain CY257 , expression of each of the known GAL gene family members
was monitored in SWI+ and swi- cells grown under inducing conditions. Primer
extension analysis (Figure 5-2) was performed on an equal amount of total RNA
prepared from the yeast strains CY340 (SWI+ and CY257 (swil- using primers
specific for the coding sequence of GALl (lanes 3 and 4), 
GAL2 (lane 5 and 6),
GAL 7 (lanes 7 and 8), GALlO (lanes 9 and 10), GALBO (lanes 11 and 12), 
MELI
(lanes 13 and 14), GAL3 
(lanes 15 and 16), and GAL5 (lanes 17 and 18). We find
that the levels of GALl, GAL2, GAL GALlO, GALBO and MELI transcripts are
not substantially altered in the swil- strain when compared to the levels detected
in the respective SWI+ strains. Likewise, transcripts from the CLN3 
gene, which
encodes a mitotic cyclin that is not involved in galactose utilization, are unaltered
in the swil mutant. However, we do detect a consistent decrease in the level of
transcription of the GAL3 and GAL5 genes (compare lane 15 to lane 16 and lane
17 to lane 18).
To verify that the GAL- phenotype displayed by swilsnfmutants is related
to the mJsexpression of either GAL3 or GAL5, 
complementation analyses were
carried out (Table 5- 2). In these experiments the SWI+ (CY340) and swil- 
(CY257)
strains described above were transformed with plasmids directing the expression
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Figure 5-2. Analysis of GAL gene transcription in S"W+ and swi- yeast.
Primer extension reactions were performed on total RNA isolated from the SWI+
yeast strain CY340 and the swil- strain CY257 using primers designed to
measure the level of transcripts for each of the indicated genes.
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of either GAL5 (line 2; pTI- , gift of D.M. Bedwell, University of Alabama,
Birmingham), GAL3 (line 4; pGAL3HA, gift of Toshio Fukasawa, Kazusa DNA
Research Institute , Japan) or the corresponding control plasmids pRS426 (line 3)
and p VTI02UHA (line 5), respectively. As expected
, the SWI+ transform ants
were able to grow on both glucose- and galactose-containing media in the presence
of antimycin (Table 5-2). On the other hand
, none of the swil- transformants was
able to grow on galactose containing media in the presence of antimycin (Table 5-
2), although they could grow on glucose-containing media in the presence of
antimycin. Overexpression of GAL3 seemed to partially suppress the growth
defect of the swi- strain (Table 5- , line 2), although it did not suppress antimycin
sensitivity.
GAL3 encodes an inducer molecule which is believed to interact with the
GAL80 protein in the presence of galactose (i.e. inducing conditions). This
interaction is thought to alter the interaction between GAL80 and the
transcriptional activator GAL4 such that the latter can now activate the
expression of downstream genes (Suzuki-Fujimoto et aI, 1996). If the Gal defect of
swilsnfmutants is indeed due to the inability of these cells to express GAL3
properly, then it is possible that this defect would be overcome by a corresponding
decrease in the expression of GAL80. To test this idea , strains CY349 (gal80L1)
and CY348 (gal80L1, swilL1) were streaked onto glucose and galactose plates
containing antimycin and growth after two days at 30 C was monitored. As
I;::
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shown in Table 5- , the deletion of the GAL80 gene did not suppress the Gal-
phenotype of the swil- strain.
If,
- .
Discussion
The results described above suggest that the Gal defect 
observed in swil snf
mutants is not simply the result of a transcriptional defect of a single member of
the GAL gene family. While the expression of two GAL genes GAL3 and GAL5
was significantly altered in a swil- strain, the presence of the respective
overexpression plasmid was not able to suppress the Gal defect. It is possible
however, that the Gal- phenotype is due to the combined misexpression of both
GAL3 and GAL5. This model remains to be tested.
The expression plasmid used in the GAL3 complementation experiment
pGAL3HA, consists of the entire GAL3 coding sequence cloned into an ADH2
expression cassette and has been shown to result in the constitutive
overexpression of HA-tagged GAL3 protein (Suzuki-Fujimoto et al, 1996).
However, in its endogenous context
, the expression of the ADH2 gene is known to
require SWIISNF, suggesting this promoter is SWI/SNF-dependent. Therefore
the pGAL3HA plasmid may not express the levels of GAL3 that are necessary to
overcome the Gal defect. In addition, the construct used in the GAL5
complementation experiment is a genomic GAL5 clone; the expression of GAL5 
this plasmid is controlled by the endogenous GAL5 promoter. Therefore
expression of GAL5 from this plasmid wil be subject to the same constraints as
IfF
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the endogenous GAL5 gene , including SWIISNF-dependence. It should be noted,
however, that both pGAL3HA and pTI-3B are high copy number constructs and
therefore the transformants tested in Table 5-2 should have a copy number 10-
times higher than th nontransformed strain.
We consistently observed small (less than two-fold) decreases in the
expression of all the other GAL genes in swil mutants (see Figure 5-2). It is
possible that the Gal defect results from the combination of these small
transcriptional defects, or from the cumulative defects in the expression of a
unique combination of GAL genes. In either event, our results do indicate that a
single gene is not responsible for the Gal defect 
observed in swilsnfmutants.
:1,
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CHAPTER VI
SUMMARY
The yeast SWIISNF complex is emerging as a paradigm for a growing class
of chromatin remodeling assemblies that appear to allow a spectrum of DNA
binding proteins access to the eukaryotic genome. Biochemical experiments
utilizing SWIISNF purified from yeast indicate the complex can modulate the
ability of DNA binding proteins to access nucleosomal binding sites (Cote et aI
1994; see also Kwon et al, 1994; Imbalzano et aI, 1994). Furthermore , the
complex can induce a persistent alteration specifically in that nucleosome within
an array which occludes a protein-DNA interaction (Owen-Hughes et aI, 1996).
More recent results have suggested that the complex may recognize the region of
the nucleosome where the DNA strand crosses over itself to form a four-way
junction-like structure (Quinn et al, 1996). This idea is supported by crosslinking
experiments which demonstrate that certain subunits of the purified complex can
interact closely with specific regions of a nucleosome in vitro and that the
specificity of these interactions is sensitive to the presence of A TP (B.
Bartholemew and C.L. Peterson, unpublished observations). All of this
biochemistry is evidence that the mechanism of SWI/SNF function involves direct
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physical contact with nucleosomes, presumably followed by alterations in histone-
DNA contacts within the nucleosome such that the DNA is more accessible.
Despite rapid progress in understanding the function of purified SWIISNF
complex in vitro, many intriguing questions regarding the function of the complex
-..
in vivo remain unanswered. For example , what dictates the SWIISNF-dependence
of gene expression? How is this relatively low abundance complex targeted to
specific sites in the genome? The work presented in this dissertation addresses
these questions by establishing the molecular basis for SWIISNF function at the
yeast GALl lO promoter. We were able to change this well characterized
SWIISNF-independent promoter into one completely dependent upon the
SWI/SNF complex for proper expression. We find that the SWIISNF-dependence
of GALl lO derivative promoters correlates with the nucleosome state of activator
binding sites in the UAS region, indicating that the role of the SWI/SNF complex
at these promoters is to modulate activator binding to nucleosomal binding sites.
These results complement the biochemical experiments described above and
provide the first evidence that the SWI/SNF complex can modulate activator
binding in vivo.
It is not clear whether the rules for SWIISNF-dependence established here
are applicable to all yeast promoters. Existing data argues that they are not , as
yeast promoters-that contain nucleosomal activator binding sites but are
expressed independently of SWI/SNF have been characterized (e.
g. 
PH05; see
previous discussion). Instead, SWIISNF-dependence may reflect a combination of
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nucleosome structure and the intrinsic binding properties of a given activator
protein. For example , activators like GAL4, which are unable to stably occupy
nucleosomal sites in vivo, wil require SWIISNF activity. In contrast, other
activators may bind nucleosomal sites in vivo without SWI/SNF modulation.
Furthermore , the SWIISNF-dependence of a particular activator may vary
depending on the individual promoter binding site. For example , we find
SWIISNF is required for complete occupancy of the two low affnity nucleosomal
GAL4 sites used in our studies but not for binding to other nucleosomal sites
which differ in binding sequence.
Our studies also address the targeting question. We find that the ability of
SWIISNF to modulate activator binding does not require a functional activation
domain. These results suggest that either the SWIISNF complex is targeted to its
site of action solely through the DNA binding domain of the activator, or that it is
not targeted at all. In the former scenario SWI/SNF could recognize some specific
feature of the DNA binding domain or, alternatively, the complex might recognize
proteins which are loosely associated with their binding sites within the context of
nucleosomal DNA. On the other hand, it is possible that SWIISNF interacts with
the genome continuously, in a random fashion, such that targeting is not
necessary. In this situation, coincidental occupation of a nucleosomal promoter
region by SWIISNF and an activator protein would lead to productive activator
binding (and eventually to transactivation). This latter model seems unfavorable
in light of the low abundance of SWI/SNF in yeast (estimated 100 copies per
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nucleus). Interestingly, the relative abundance of SWIISNF complex in human
cells is much higher than in yeast.
Finally, there has been much controversy recently over the observation of
Wilson et al (1996) that the yeast SWI/SNF complex is a component SRB-
containing mediator complex and therefore of the RNAPII holoenzyme itself.
These authors theorize that holoenzyme recruitment, which has been shown to
result in transcriptional activation (reveiwed in Ptashne and Gann, 1997) would
bring SWIISNF to the promoter where it could then alter chromatin structure.
However, Cairns et al (1996b) were unable to detect an association between
SWIISNF and holoenzyme complexes.
The results presented in Chapter IV of this thesis address this issue. Our
results indicate that a GAL4 derivative lacking an activation domain (GAL4 DNA
binding domain construct MA424) remains sensitive to SWI/SNF activity,
suggesting that this complex is able to reach the promoter independently of
holoenzyme. Furthermore , while we do see some co-purification of SRB subunits
with SWIISNF complex in our preparations, the amounts represent less than 20%
of the SRB subunits in a yeast lysate (L. Boyer and C.L. Peterson, unpublished
observations). Taken together, these data suggest that the SWIISNF complex is
physically and functionally independent of holoenzyme. It remains possible that
the complexes are able to interact in vivo, either directly or indirectly, and that
this association results in small amounts of co-purification.
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Finally, recent studies from a number of groups have verified the
importance of protein acetylation/deacetylation in transcription (reviewed in
Pazin and Kadonaga, 1997). Interestingly, some of the gene products found to be
involved in histone ac;etylation also interact genetically with the SWIISNF
complex (K. Pollard and C.L. Peterson), suggesting that SWIISNF may playa
direct or regulatory role in this aspect of transcription regulation. The strains and
techniques developed in this thesis will allow a careful analysis of the role of these
other factors in transcription factor binding, transactivation and SWIISNF
regulation in vivo.
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APPENDIX A
DETAILED PROTOCOLS
Isolation of yeast 'nuclei
The following protocol was obtained from Randall H. Morse (Molecular
Genetic Program, Wadsworth Center, New York State Department of Health
and SUNY School of Public Health , Albany, NY 12201-2002) and is based on
a procedure published in Shimizu et al (1991) EMBO J. 10 , 3033-3041.
1. Grow 1 L of cells to OD600 of 0. 1.4
(The procedure can be scaled up, e.g. grow 4 L of cells and multiply all
reagents used by 4.
2. Harvest cells by centrifugation for fifteen minutes at 4K rpm in a J6 rotor.
3. Wash pelleted cells in 50 ml of S Buffer. Spin as above for five minutes.
4. Incubate cells in 25 mL S Buffer at 30 C for ten minutes. This can be done
in a shaking incubator (20 rpm) or in a standing incubator. Spin cells as
above for five minutes.
5. Drain pellet and weigh. Add volume of S Buffer equal to four times the
weight of the pellet (for example , 10 ml to a 2. 5 g pellet).
6. Digest cells with 1 ml10 mg/mll00T Zymolyase.
7. Incubate 30-90 minutes at 30 C with gentle shaking (60 rpm) until cells
are well spheroplasted. This can be monitored by lysing the cells in 0. 1% SDS
under a microscope; if cells are well digested ::90% of them should lyse under
these conditions. I have found that 45 minutes is usually sufficient.
Remaining steps should be carried out in the cold using chilled
buffers.
8. Dilute sample to 30 ml with S Buffer. Spin five minutes at 4K.
9. Wash spheroplasts twice more in cold S Buffer, about 30 mL each time.
The supernatant from these washes will be progressively cloudy.
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10. After the second wash, resuspend the pellet in 19 ml F Buffer.
Mechanically disrupt the spheroplasts by passing through a homogenizer. I
found four passes through a Yamata LH-21 homogenizer set at 100 rpm
provided sufficient disruption. Disruption can be monitored under a
microscope. Dilute the sample enough to see individual cells 
-- there should
be a lot of smallish debris visible and very few intact, live cells.
11. Layer homogonized sample onto 19 ml ofGF Buffer in an Oak Ridge tube.
Spin 13. 5K rpm (21 625 X g) in a JA20 rotor for 30 minutes at 4 C. Note: You
will need glycerol in a balance tube to achieve sufficient density to balance!
12. Discard supernatant. Resuspend pellet in 20 ml of F Buffer.
Mechanically resuspend pellet with a wooden stick to dislodge it from the
bottom of the tube. Vortex for five minutes at 4 C to thoroughly resuspend
the pellet.
13. Spin sample for fifteen minutes at 4K rpm in J6 rotor at 4
14. Transfer supernatant to a fresh tube. Spin at 13.5K rpm (21 625 X g) in a
JA20 rotor for 25 minutes at 4 C to isolate nuclei. Nuclei should be a white
pellet, fairly large and homogeneous looking.
15. Discard supernatant and drain nuclei pellet.
16. Resuspend nuclei pellet in 4 ml of D buffer (to make a final concentration
of approximately 6 X cell equivalents/ml). Quick freeze 1 ml aliquots in
eppendorf tubes in liquid nitrogen and store at -
S Buffer
F Buffer
GF Buffer
D Buffer
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Solutions
1.4 M Sorbitol
40 mM HEPES pH 7.
5 mM MgCb
10 mM B-mercaptoethanol (added fresh)
ImM PMSF (added fresh)
18% w/v Ficoll 400
20 mM PIPES pH 6.
5 mM MgCb
1 mM PMSF (added fresh)
20% w/v glycerol
7% w/v Fico1l400
20 mM PIPES pH 6.
5 mM MgCb
1 mM PMSF (added fresh)
10 mM HEPES pH 7.
5 mMMgCb
05 mM CaCb
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i , In vivo DMS footprinting
The following protocol is based on that of Giniger et al (1985 Cell 
767-774. ) and a detailed protocol received from Jeff Axelrod 
 as a supplement
to the protocols in Axelrod and Majors (1989 NAR : 171- 183.) and Axelrod
et al (1993, G&D 1: 857-869).
I. PREPARTION' OF METHYTED GENOMIC DNA
1. Grow 100 ml yeast culture in appropriate rich medium to an OD600 of 1.5-
, corresponding to a density of 5 x 10 7 cells/ml. Cells grown in minimal
medium should be grown to an OD600 between 0.5 and 0.75. Minimal
cultures grown over 0.75 are saturated and consistantly demonstrate poor
GAL4 footprinting.
2. Pellet at 4K for 7 minutes.
3. Resuspend in 1.5 ml of the same growth medium. Incubate at room
temperature for five minutes.
4. Add 2J.l DMS and vortex well. Incubate two minutes at room temperature.
Note: Use only fresh DMS (less than 4 months old)
Also , DMS is nasty stuff. Have a beaker with 100 m15N NaOH
(20g NaOH pellets/l00 ml dH20) ready to inactivate DMS tips and
waste.
5. Quench reaction with 40 ml of ice cold TEN.
6. Pellet at 4K for 7 minutes.
7. Wash pellet in 1 ml SCED. Spin as above.
8. Resuspend pellet in 1 ml SCED. Transfer to a 1.5 ml Eppendorftube and
add 100 J.II0 mg/mll00 T Zymolyase (Seikagaku Corporation; DO NOT USE
LESS PURE THAN lOOT!). Invert tubes to mix well.
9. Incubate at 37 C for 25 minutes. Monitor spheroplasting under
microscope. When spheroplasting is complete , you should see ::90% lysis
when water or 0. 1% SDS is added to spheroplasts.
10. Pellet spheroplasts for 1 minute. Decant supernatant.
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11. Resuspend spheroplasts in 1 ml of 50mM Tris pH 8. 20 mM EDTA.
Resuspension into a homogeneous solution will require careful repeated
pipetting. Transfer half of the suspension to a second Eppendorf tube.
12 Lyse spheroplasts by adding 50 J.II0% SDS to each tube. Incubate at
C for 30 minutes.
13. Add 3J.l 20mg/ml Proteinase K, mix by inversion and incubate 30 minutes
more at 37
14. Add 200 J.l 5M potassium acetate pH 8.0 to each sample and incubate on
ice for at least one hour.
15. Spin samples 5 minutes at room temperature. Transfer supernatant to
fresh tubes , spin again for 5 minutes at room temperature, transfer
supernatant to another fresh tube and preciptate with 700 J.l isopropanol.
16. Pellet nucleic acid in microfuge (3-5 min), rinse pellets with 70% ethanol
and air dry approximately 10 minutes.
17. Resuspend pellets in 300 J.l TE. Add 30 J.g RNAse (DNAse-free) to each
sample and incubate 37 C for one hour. Pellets may not resuspend readily,
but will go into solution after incubation at 37 C with a little intermittent
vortexing.
18. Combine samples into one tube. Spin for two minutes on highest setting
to remove insoluble debris. Transfer supernatant to a fresh tube.
19. Precipitate DNA by adding 5.5 ullM spermidine , pH 4.0. Flick the tube
after spermidine addition. A white , threadlike precipitate should form. This
may require another 5.5 J.l aliquot of spermidine (final spermidine
concentration should be 3-9 mM). Incubate on ice for at least fifteen minutes.
Note: Preciptation of DNA by spermidine is critical to the primer extension
assay later. Use a 1M stock of spermidine , pH 4. THE PH OF THE
SPERMIDINE IS CRITICAL!
19. Pellet DNA by centrifugation for two minutes. It is a good idea to check
the efficiency of the spermidine precipitation on an agarose gel. I typically see
80-90% of the DNA in the pellet.
,! 
d"'
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20. Resuspend the spermidine pellet in 300 
J.l O. IM Tris pHS.O. Incubate at
C for two hours with some vortexing. It wil take almost this entire
incubation for the pellet to dissolve.
21. Add 165 III 7. 5M ammonium acetate and 1 ml ethanol. Chil on dry ice for
15 minutes. Spin, wash and dry pellet.
22. Resuspend pellet in 100 J.l dH20. Addition of salt will help the
dissolution process, so add the salt required of the digestion reaction and
incubate at 37 C for a few minutes until the pellet dissolves readily upon
vortexing. I typically set up a 200 J.l digestion reaction using the entire
sample.
Note: The digestion of the genomic DNA into smaller fragments will facilitate
the primer extension reaction. Choose an enzyme which cleaves outside the
region you are footprinting, including the primer binding site.
23. Extract the digestion with phenol/chloroform/isoamyl alcohol and
precipitate with 1/10 volume 3M sodium acetate pH 5.2 and 2. 5 volumes of
ethanol.
24. Spin, wash and dry pellet. Resuspend in 15 J.l dH20; this will give
approximately 1J.g/J.l.
NOTE: I have been able to get very clean, reproducible footprints without
using a piperidine cleavage step. (In fact, I have had trouble with high
background when I use piperidine.) Therefore , proceed directly to the primer
extension step.
II. PRIMER EXTENSION
1. Set up primer extension reactions in 0.5 ml eppendorftubes:
5 J.l methylated, restricted DNA (from step I)
5 J.l 500 J.M dNTP Mix
5 J.l5X Taq Buffer
3 J.l end-labelled oligonucleotide (3ng)
5 J.l (2.5 Units) Sequencing grade Taq Polymerase* (Promega)
dH20 to make a 25 J.l reaction
Note: This is the only polymerase that has worked for me.
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2. To make a guanine ladder, use the same amount ofUNMETHYLATED
DNA (isolated exactly as described above , simply omit DMS treatment) and
instead of using the 500 J.M dNTP mix, use 5J.l of 5X G Mix in the primer
extension reaction.
3. Overlay samples with 50J.l mineral oil and cycle for two minutes each at
C/(T m + 2 C)170 C 19 times.
Note: To determine appropriate T m, use the formula below:
Tm = 81.5 + 1.6. (10g M) + 0.41(%GC) - 500/n
M = molarity of salt in buffer, here 0.059 M
n = length of oligonucleotide
5. When cycling is finished, add 75 J.l dH20 to each sample and extract with
100 J.l chloroform/isoamyl alcohol. Precipitate with 5 J.l3M sodium acetate
pH 5.2 and 165 J.l ethanol.
6. Collect sample by centrifugation, wash pellet with 70% ethanol and air dry10 minutes. 
Note: Do not overdry pellet or it wil be harder to resuspend!
7. Resuspend pellet in 5 J.l Loading Buffer. Vortex well and check
resuspension (-c20% of the counts remain in the tube when the sample liquid
is removed).
8. Boil samples 5 minutes , remove to ice , and load entire sample on a
denaturing gel. Use a 0.4 mm thick gel to increase resolution. With this
thickness, low percentage gel can be used, I usually pour a 5% gel.
III. PREPARING A SEQUENCING LADER
While the primer extension reactions are cycling, I usually prepare sequencing
markers. This ladder is not necessary if you make a genomic G ladder when
you do the primer extension reaction (see above). This is a modification of the
Sequenase protocol and uses the same reagents.
1. Add 1 J.l (lJ.g) plasmid DNA and 19 J.l dH20 to an eppendorftube.
2. Add 2 J.12N NaOH and incubate 5 minutes at roo temperature.
"I,.3:
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3. Precipitate with 3 J.l 3M sodium acetate pH 5.2 and 75 J.l ethanol.
4. Chill on dry ice 10 minutes , spin, wash and dry pellet.
5. Resuspend pellet in 10 J.12X Sequenase Buffer. Add 3 J.l end-labelled
oligo and 7 J.l dH20:
6. Boil 1 minute and incubate at 37 C for 10 minutes.
7. Spin briefly. Aliquot 4.5 J.l to each of four tubes containing 3.2 J.l ddNTP
mix. Add 1 J.l of diluted SequenaseCI (1:8 in Enzyme Dilution Buffer) to each
tube and incubate at 37 C for 5 minutes.
8. Ethanol precipitate with 1 J.13M sodium acetate, pH 5.2 and 30 J.l ethanol.
Chill on dry ice and spin. Wash and dry pellet and resuspend as above for
primer extension samples.
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Solutions I
TEN 10 mM Tris pH 8.
1 mM EDTA pH 8.
40mM NaCl
SCED 1 M Sorbitol
100 mM Sodium Citrate pH 5.
10 mM EDTA
2 mM DTT
Solutions II
5X Taq Buffer 250 mM Kcl
50 mM Tris pH 8.
12.5 mM MgCh
850 ug/ml BSA
5X G Mix 1 mM ddCTP
25 J.M dCTP
5 mM dATP
5 mM dTTP
5 mM dGTP
Loading Buffer 95% formamide
20 mM EDTA
05% Bromophenol Blue
05% Xylene Cyanol FF
Solutions In
5X Sequenase Buffer 200 mM Tris-HCl, pH 7.
100 mM MgC12
250 mM NaCl
Enzyme Dilution Buffer 10 mM Tris-HCl, pH 7.
5 mM DTT
5 mg/ml BSA
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Indirect end-labelling
I. PREPARATION OF FREE DNA
1. Thaw two frozen 1 ml aliquots of nuclei at room temperature.
2. Add 80 J.l10% SDS and 30J.l20 mg/ml Proteinase K to each.
3. Incubate at 37 C for two hours.
4. Add 180 J.I 5 M potassium acetate and incubate on ice for one hour.
5. Spin samples at room temperature in microfuge for 10 minutes. Transfer
supernatant to a fresh tube, repeat if necessary (sometimes it is impossible
to avoid the pellet after the first spin).
6. Precipitate supernatant with an equal volume of isopropanol.
7. Resuspend the washed pellet in 300 J.l water and reprecipitate.
Note: Do NOT overdry the pellet or it wil be impossible to resuspend.
8. Resuspend the washed pellet in 1 ml of Buffer D2
Note: Free DNA must be resuspended in a buffer containing high cation
concentrations to compensate for the loss of these ions due to coating of the
phosphate backbone.
II. MNASE DIGESTION
1. Thaw 2 frozen 1 ml aliquots of nuclei at room temperature.
2. Aliquot 325J.l into six eppendorftubes. Do the same for the Free DNA
samples from above.
3. Dilute MNase stock to 5 Units/J.l with Buffer D. Serial dilute this 5
Units/J.l stock in Buffer D to make 0. , 0.05 and 0.005 Units/J.l.
4. Prewarm sample tubes at 37 C. Digest with MNase (0 to 50 Units) for
five minutes at 37
1''
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5. Stop reactions with 26 J.II0% SDS and 10 J.120 mg/ml Proteinase K.
Incubate samples at 37 C for two hours.
..-
6. Add 60 J.l5 M potassium acetate , mix well and incubate samples for at
least one hour on ice.
7. Spin samples in' a microfuge for ten minutes at room temperature.
Transfer supernatant to a fresh tube and precipitate with 350 J.l isopropanol.
8. Spin, wash and dry pellets. Resuspend in 150 J.I TE pH 8.0. Add 5 J.g
RNase and incubate at 37 C for 30-60 minutes.
9. Precipitate DNA with 2.25 J.ll M spermidine pH 4.0. Incubate on ice for
at least 15 minutes.
10. Pellet the DNA and resuspend in 150 J.I O. IM Tris pH 8.0. Incubate at
C until pellets are easily resuspended upon vortexing (10-30 minutes).
11. Precipitate DNA with 82.5 J.l 7.5 M ammonium acetate and 500 J.l
ethanoL
12. Spin, wash and dry pellets. Resuspend in 15 J.l of sterile water.
III. SOUTHERN ANALYSIS
1. Electrophorese samples on a 1.5% agarose gel overnight (longest gel size).
2. Soak gel in 0.25% HCL
3. Rinse gel in sterile water.
4. Soak gel in Southern Solution D for 30 minutes at room temperature with
gentle agitation.
5. Rinse gel once in Southern Solution N and then soak in this solution for 15
minutes at room temperature with gentle agitation. Discard solution and
soak gel in fresh Southern Solution N for 15 more minutes as above.
6. Transfer DNA to nylon membrane (QuiabraneQY) by capilary action (see
Maniatis). Transfer should be carried out in 20X SSC for at least 12 hours.
7. When transfer is complete , mark origin in pencil on membrane.
Autocrosslink DNA to the membrane (StratalinkerQY) and air dry 15 minutes
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at room temperature. If necessary, membrane can be stored between two
pieces of 3MM filter paper at 4
8. Pre-hybridize membrane for 1-4 hours at 42 C in freshly prepared
Prehybridization Solution.
9. Hybridize membrane for at least 12 hours at 42 C in 5 ml Hybridization
Solution containing lX10 cpm/mllabelled DNA probe. Be sure to denature
double stranded DNA probes by boiling for 5- 10 minutes before use.
10. Wash membrane twice for five minutes at room temperature in 2 X SSC,
1 % SDS.
11. Wash membrane in O. IX SSC, 0. 1% SDS for 15 minutes at hybridization
temperature (or higher if necessary). Repeat if necessary.
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Solutions I
Buffer D2 10 mM HEPES pH 7.
5 mM MgCh
2 mM CaCh
Solutions II
MN ase stock 15 U nits/ml in Digestion Buffer
Digestion Buffer
Buffer D 10 mM HEPES pH 7.
5 mM MgCh
05 mM CaCh
TE pH 8. 10 mM Tris-HCl pH 8.
1 mM EDTA pH 8.
Solutions III
1.5% agarose gel 1.5% agarose in IX TBE (0.089 M Tris base , 0.089
M boric acid , 20 mM EDTA pH 8.
Southern Solution D 0.4 N NaOH
6 M NaCl
Southern Solution N 1.5 M NaCl
5 M Tris-HCl pH 7.
20X SSC 3 M NaCl
3 M sodium citrate
Adjust pH to 7.0 with 1 M HCl
Pre-hybridization Solution 6X SSC
50% formamide
5X Denhardt's Solution
50 mM sodium phosphate pH 6.
100 J.g/ml salmon sperm DNA
5% SDS
Hybridization Solution 5X SSC
50% formamide
II;
ir.
100X Denhardt's Solution
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IX Denhardt's Solution
50 mM sodium phosphate pH 6.
100 J.g/ml salmon sperm DNA
1% SDS
2% Ficoll 400
2% polyvinylpyrrolidone
2% BSA
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Nystatin permeabilization of spheroplasts
This protocol is based on that published in Venditti and Camilloni
(1994 , Mol. Gen. Genet. 242 : 100- 104.) and that worked out by Monique
Mukrit at UMMC.
1. Grow 200 ml of yeast culture in YEPD.
2. Harvest cells by centrifugation for ten minutes at 4K rpm in a J6 rotor.
3. Resuspend cell pellet in 20 ml Pre-spheroplasting Buffer and add 86 J.l B-
mercaptoethanol to make a final concentration of 60 mM.
4. Incubate cells at room temperature for ten minutes.
5. Spin cells as above.
6. Resuspend pellet in 10 ml Spheroplasting Buffer and add 7.2 J.l B-
mercaptoethanol to make a final concentration of 10 mM.
7. Remove 20 J.l of cell suspension, mix with 980 J.l dH20 , and record OD6oo.
8. To the remainder, add 200 J.l recombinant lyticase.
9. Incubate at 37 C until OD6oo is decreased by 90% (usually 10- 15 minutes).
10. Spin spheroplasts at 4K rpm for ten minutes in the cold.
11. Wash spheroplasts in 750 J.l Nystatin Buffer.
12. Resuspend washed spheroplasts in 1.5 ml Nystatin Buffer.
13. Add 30 J.l 10 mg/ml nystatin.
14. Aliquot 250 J.l of cell suspension to six eppendorf tubes.
15. Permeabilized spheroplasts can now be digested as desired, i.e. with
MNase (for titration or indirect end-labeling experiments) or with restriction
enzymes (for accessibility assays).
16. To stop digestion, add 1/10 volume of SDS/EDTA Stop Solution to each
sample.
---- -_. - -
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Solutions
Pre-spheroplasting Buffer 100 mM Tris-HCl, pH 7.
Spheroplasting Buffer 7 M sorbitol
75% yeast extract
1.5% peptone
10 mM Tris-HCl, pH 7.
Nystatin Buffer 50 mM NaCl
1.5 mM CaC12
20 mM Tris-HCl, pH 8.
1 M sorbitol
SDS/EDTA Stop Solution 10 % SDS
50 mM EDTA
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APPENDIX B
RELATED EXPERIMENTS
The preprint included in this appendix contains the restriction enzyme
accessibility assay experiments described in Chapter 3 (see p. 78). This
manuscript is scheduled for publication in the August 1997 issue of Molecuar
and Cellular Biology. While the experiments in question were not performed
by the author of this thesis, the results are directly relevant to the work
presented herein.
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The Yeast SWI -SNF Complex Facilitates Binding of a
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The Saccharomyces cerevisiae SWI-SNF complex is a 2-MDa protein assembly that is required for the function
of many transcriptional activators. Here we describe experiments on the role of the SWI-SNF complex in
activation of transcription by the yeast activator GAL. We find that while SWI-SNF activity is not required
for the GAL4 activator to bind to and activate transcription from nucleosome-free binding sites, the complex
is required for GAL to bind to and function at low-affnity, nucleosomal binding sites in vivo. This SWI-SNF
dependence can be overcome by (i) replacing the low-affnity sites with higher-affnity, consensus GAL binding
sequences or (ii) placing the low-affnity sites into a nucleosome-free region. These results define the criteria
for the SWI-SNF dependence of gene expression and provide the first in vivo evidence that the SWI-SNF
complex can regulate gene expression by modulating the DNA binding of an upstream activator protein.
The SWI-SNF complex is required for the expression of a
number of diversely regulated genes in the yeast Saccharomy-
ces cerevisiae. The results of genetic experiments indicate that
the SWI -SNF requirement reflects the ability of the complex to
antagonize chromatin-mediated transcriptional repression
(26). In these studies , mutations in genes that encode chroma-
ti components, including HHT1 (encoding histone H3),
HHFl (encoding histone H4), and SIN1 (encoding an HMG-
like protein which is thought to be a chromatin component),
were found to alleviate the transcriptional defects of swi mu-
tants (14, 15). In addition, alteration of relative histone levels
by deletion of one of the two endogenous HTA1-HTB1 gene
clusters (encoding histones H2A and H2B) is also able to
partially restore transcriptional activity to swi-snf cells (12).
These results suggest that the SWI-SNF complex acts to pro-
mote the expression of genes within the context of a compact
eukaryotic genome.
The primary level of chromatin architecture in viv() is the
cleosome. The results of in vivo and in vitro studies indicate
that nucleosomes inhibit transcription by competing with tran-
scription factors for occupancy of DNA binding sites (for a
review, see reference 27). In vitro, nucleosomes can inhibit
transcription initiation either by blocking access of the general
transcription machinery to promoter sequences or by hinder-
ing the binding of upstream activator proteins. It is not known
at present which of these steps might be overcome by the
SWI-SNF complex in vivo. The results of biochemical studies
have shown that yeast or human SWI-SNF complex can stim-
ulate the binding of an activator protein to a nucleosomal
binding site (5, 16). Furthermore, the purified human SWI-
SNF complex can facilitate the binding of the general tran-
scription factor TATA box binding protein (TBP) to a posi-
tioned nucleosome (13). Therefore, the SWI-SNF complex
may function at one or more discrete steps to facilitate gene
expression in vivo. 
In this study, we address the ability of the SWI-SNF complex
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to facilitate the binding of a transcriptional activator to up-
stream activation sites (UASs). To do this, we monitored the
transcriptional activity and DNA binding of the yeast activator
GAl to derivatives of the UAS of the divergently transcribed
GALl and GALlO genes. These UAS derivatives differ in the
affnity of the GAl binding sites as well as the nucleosomal
context of these sites. We find that the SWI-SNF complex is
required for GAl to activate transcription from a promoter
containing two low-affnity, nucleosomal binding sites in vivo.
In addition, we show that the SWI-SNF dependence of this
promoter reflects, in part, the ability of the complex to facili-
tate GAl binding to these nucleosomal sites.
MATERIS AND METHODS
(3-Galactosidase assays. Strains were grown in minimal medium containing
2% galactose , 0,5% sucrose , and all the amino acids except histidine to an optical
density at 600 nm (00600) of 0,5 to 0.9. Assays were performed (23) on three
transformants, and Miler units (19) were averaged, Standard deviations were
25%, j3-Galactosidase activity from all strains in the absence of GAI expres-
sion was 1 Miler unit.
In vivo footprinting. Intact cells were treated with dimethyl sulfate (OMS),
and the methylated DNA was isolated essentially as previously described (10),
except final pellets were dissolved in water and quantitated with a spectropho-
tometer. DNA samples were then digested with HaeIII and analyzed via a cyclic
primer extension reaction (1) using a labeled oligonucleotide, Primer extension
products were extracted with chloroform-isoamyl alcohol (24:1), precipitated
and electrophoresed on a 5% National Diagnostics sequencing gel. The gel was
dried and exposed to film for 12 to 48 h. For a control for spurious primer
extension products, DNA from a strain that was not treated with OMS was also
prepared. Footprinting at the wild- type GALl lO VAS (see Fig. 2) was analyzed
by using an oligonucleotide with the following sequence: 5' GAG CCC CAT
TAT er AGC- , which anneals to a sequence located 60 bp upstream of
GAI binding site 1. Footprinting at the integrated reporter loci (see Fig. 3) was
analyzed by using an oligonucleotide with the following sequence: 5' -CCG GeT
CGT ATG TIG TGT GG- . This oligonucleotide anneals to the unique pVC
sequences located upstream of the GAI binding sites in the reporters (see
below),
Indirect end labeling. Nucl i were prepared as described previously (22). To
prepare free DNA, 80 fl1 of 10% sodium dodecyl sulfate (SDS) and 30 fl1 of
20-mg/ml proteinase K were added to a 1-ml aliquot of nuclei (approximately 5 X
cell equivalents), and the sample was incubated at 37 C for 2 h. Lysed nuclei
were treated with 180 fl1 of 5 M potassium acetate on ice for 1 h and subjected
to centrifgation, and the supernatant was precipitated with isopropanol. This
DNA sample was resuspended in water and reprecipitated with ethanol. The
resultant free DNA was resuspended in 1 ml of buffer 02 (10 mM HEPES (pH
7.3), 5 mM MgCl , 2 mM CaCl ). Free DNA and nuclei samples (approximately
1.7 X 10 cell equivalents in 300-fl1 aliquots) were digested with 0 to 50 
micrococcal nuclease (MNase) for 5 min at 37 C. Reactions were halted by
adding 26 fl1 of 10% SDS and 10 fll of 20-mg/ml proteinase K and incubating the
4811
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I:: mixures at 37 C for 2 h, Samples were treated with 60 fLl of 5 M potassium
acetate on ice for 1 h and subjected to centrifugation , and the supernatant was
precipitated with isopropanol. DNA was then digested with either 
Clal (see Fig.
4A and B) or EcoRl (see Fig, 4C) in the presence of RNase, Digested fragments
were extracted with buffered phenol , and the aqueous layer was precipitated with
ethanol. Final pellets were electrophoresed on a 1.5% agarose gel overnight.
DNA was transferred to a nylon membrane, and blots were probed with an
internally labeled 870-bp lacZ fragment (see Fig, 4A and B) or an internally
labeled 550-bp fragment from the GALl gene (see Fig. 4C).
HgaI restriction enzyme accessibilty assay. Permeabilized spheroplasts were
prepared from exponentially growing cells (OD6oo of 0. , in glucose medium) by
treatment with yeast lyticase (24), Briefly, cells were harvested, resuspended in
1/10 culture volume of prespheroplasting buffer (100 mM Tris (pH 8.0), 60 mM
i3-mercaptoetha l), and shaken for 10 min at room temperature. Cells were
harvested and resuspended in 1/20 culture volume of spheroplasting buffer (0,
M sorbitol , 0.75% yeast extract, 1.5% peptone, 10 mM Tris (pH 7,5), 10 mM
i3-mercaptocthanol), lyticase was added , and cells were incubated at 37 C until
the ODooo of cells diluted with water was decreased by 90% (30 to 40 min),
Spheroplasts were harvested by centrifugation, washed once with nystatin buffer
(50 mM NaC!, 1.5 mM CaC!z, 20 mM Tris (pH 8), 1 M sorbitol, 10 mM MgCl
and resuspended in 1/150 culture volume of nystatin buffer. Nystatin was added
to a final concentration of 15 fLg/ml, and spheroplasts were incubated at 37 C for
5 min. Hgal (New England BioLabs) was added to the permeabilized sphero-
plasts at a concentration of 120 U/ml , and samples were incubated at 37 C for 0
to 30 min. Reactions were stopped by the addition of 1/5 volume of 5% SDS-
mM EDTA, and DNA was purified as described above (a negative control lacked
Hgal). Purified DNA was digested with HindUl (New England BioLabs), elec-
trophoresed on a 1.5% agarose gel, Southern blotted to a nylon membrane, and
probed with a 500-bp EcoRl fragment from plasmid pLB8 that was internally
labeled by random priming (see Fig, S). Results were quantitated by phosphor-
imager analysis,
Plasmid and strain construction. The following plasmids have been described
previously: pRY171 (GALl- lacZ fusion (30)), pEG202 (pLEXA (ll)), and
pMA10 (pGAL) and pSD15 (17). Plasmids pLB7 and pLB8 were constructed
by inserting the 194-bp Smal-Pvull fragment of pUC18 (29) between the URA3
gene and the GAL binding sites of the plasmids pEG44 and pEG28, respec-
tively (9). Plasmid pEG28 contains GAL binding sites 3 and 4 positioned 190 bp
upstream of the GALl TATA element. These sites are separated by 62 bp
(center-to-center distance), Plasmid pEG44 contains two synthetic, consensus
GAL binding sites positioned 150 bp upstream of the GALl TAT A element (9).
These two sites are separated by 32 bp ( center-to-center distance), These plas,
mids were targeted for integration at the ura3-52 locus of yeast strains CY524
CY525, and CY526 (Table 1) by digestion with ApaI. A DNA fragment contain-
ing the 5S nucleosome positioning element (NPE) of sea urchin was amplified
from plasmid plCN5S182 (gift from Jerry Workman) by PCR using the following
primers: 5' CCACGAATAACICCAGGG-3' and 5' CCCCGAGGAATTAA
GTAC-3' (18). The 182- bp PCR product was inserted into plasmid pLB8 , 20 bp
upstream of GAL binding site 3 (see Fig. 1), This new plasmid, called pLBI6
was targeted for integration at the ura3-52 locus of CY524, CY525 , and CY526
by digestion with ApaI. Yeast transformations were performed via the lithium
acetate method described previously (8).
RESULTS
SWI-SNF activity is required for transcriptional activation
by GAI at some promoters. Isogenic SWl+ and swi- strains
that contain similar single-copy integrated reporters were con-
structed and are shown schematically in Fig. 1A. Strains
CY353 (swr+ and CY366 (swir) contain a GALl lO VAS
reporter consisting of four GAl binding sites upstream of a
GALl- lacZ fusion gene (reporter a). Strains CY401 (swr+
and CY422 (swir) contain a derivative of this reporter that
contains only two of these low-affnity GAl binding sites
(sites 3 and 4; reporter b); strains CY532 (swr+ and CY534
(swir) contain a version of reporter b that contains 192 bp of
additional plasmid sequences 20 bp upstream of GAl site 3
(reporteJ;)c); strains CY528 (swr+ and CY530 (swir) con-
tain a reporter which contains two high-affnity, consensus
GAl binding sites in place of the two low-affnity sites (re-
porter d) (9). I3-Galactosidase assays were performed on these
strains to monitor GAl transcriptional activity either in the
presence of endogenous concentrations of GAl (pLEXA
columns) or under conditions in which GAl is overexpressed(pGAl columns) (Fig. 1A).
In the absence of functional SWI-SNF complex, transcrip-
tional activation by GAl from the wild- type GALl, lO VAS
. ,"-'
TABLE 1.
MoL. CELL. BIOL. I '
Yeast strains used in this study I '
GenotypeStrain
CY257 
..............
MATa swill:::LEU2Iys2-801 ade2, lOlleu2-!: his3,
1:200 ura3-!:9
CY296 MATa gaI41:::LEU2 lys2-801 ade2-101Ieu2-1:1 his3-
1:200 ura3-!:9
CY297 MATa gaI41:::LEU2 swill:::LEU2 lys2,801 ade2-101
leu2- 1:1 his3-1:200 ura3-!:9
CY341 
.. .
MATa lys2-801 ade2-101Ieu2-!: his3, 1:200 ura3-
CY353 .............. Same as CY524 but contains URA3::pRY171
(GALl, 10)
CY366 MATa swi11:::LEU2 ura3-52 ade2- 101 his3-1:200 leu2,
1:1lys2-801 URA3::pRY171 (GALl,lO)
CY401.............. Same as CY524 but contains URA3::pEG28 (2 low)"
CY422 ..........,...Same as CY526 but contains URA3::pEG28 (2 low)
CY524 
.
MATa lys2-801 ade2-101Ieu2-1:1 his3-1:200 ura3-
CY525 
...
MATa gaI41:::LEU2 lys2-801 ade2-101Ieu2-!: his3-
1:200 ura3-
CY526 
.. .
MATa swi11:::LEU2 lys2-801 ade2-101Ieu2-1:1 his3-
1:200 ura3-
CY528 ..............Same as CY524 but contains URA3::pLB7 (2 high)b
CY529 .......,......Same as CY525 but contains URA3::pLB7 (2 high)
CY530 .............. Same as CY526 but contains URA3::pLB7 (2 high)
CY532 ..............Same as CY524 but contains URA3::pLB8 (2 low;
pUC spacer)
CY533 .............. Same as CY525 but contains URA3::pLB8 (2 low;
pUC spacer)
CY534 ....,.........Same as CY526 but contains URA3::pLB8 (2 low;
pUC spacer)
CY586 ..............Same as CY524 but contains URA3::pLB16 (2 low;
NPE)
CY587 .............. Same as CY525 but contains URA3::pLB16 (2 low;
NPE)
CY588 .............Same as CY526 but contains URA3::pLB16 (2 low;
NPE)
2 low, two low,affnity GAL4 binding sites.
" 2 high , two high-affnity GAL4 binding sites,
region is reduced only 1.5-fold from the activity in the respec-
tive wild-type strain (Fig. lA, reporter a). This result is con-
sistent with a previous study in which it was found that 
GALl
expression was only weakly affected by swi-snf mutations (21),
In contrast, GAl activity on the two reporters with two low-
affnity GAL4 binding sites is SWI-SNF dependent; transcrip-
tional activity is reduced 22- to 32-fold in the swir strains
from that of the wild-type strain (Fig. lA, reporters b and c),
When these two low-affnity sites are replaced by two high-
affnity, consensus GAL4 binding sites, transcriptional activa-
tion is reduced only 1.3-fold in the swil- strain from that of the
wild-type strain (Fig. lA, reporter d).
Strains harboring the two low-affnity site reporters were
also distinct from those carrying the two high-affnity site re-
porters in that lacZ expression was increased 2.5- to 3. fold
when GAL4 protein was overexpressed (Fig. lA, reporters b
and c; also data not shown). The simplest interpretation of this
result is that physiological levels of GAL4 are not suffcient to
fully occupy the two low-affnity sites (9; also see below). Im-
portantly, overexpression of GAL4 does not overcome the
SWI-SNF dependence of this reporter (Fig. lA, reporters b
and c). It should be noted that the swil mutation does not
affect expression of GAL4 from this overexpression plasmid in
this strain background (Fig. lB) (20).
SWI-SNF is required for GAI occupancy of low-affnity
binding sites in vivo. To directly assess the ability of GAL4 to
bind its sites in the different reporter strains in the presence or
absence of SWI-SNF, we used an in vivo DMS footprinting
assay. GAl protects guanine residues at each end of its 17-
LaCZ 2311 1726 (75%) 2719 1616 (59%)
LacZ 613 490 (80%)
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pGAL4
swil- SWJ+ swil-
4691 (65%)
C?L4 
16 (4.1 %) 1118 51 (4.5%)
30 (4.5%) 2409 74 (3%)
FIG, 1. GAL requires functional SWI-SNF complex to activate transcription from two low, affnity binding sites. (A) i3-Galactosidase assays were performed on
isogenic SWl+ or swir strains harboring the integrated GALl, /acZ UAS reporter plasm ids pRYl71 (a), pEG28 (b), pLB8 (c), pLB7 (d), or pLB16 (e), GAL 
binding
sites are denoted by the small black boxes. GAL sites numbered 1 to 4 indicate sites from the GALl lO UAS region; GAL sites numbered 17 
indicate synthetic
consensus GAL binding sites. Strains contained plasmids that overexpressed either the bacterial LexA DNA binding domain (pEG202) or the full-length GAL4 protein
(pMA21O), Numbers in parentheses show activities as percentages of the wild- type levels. i3-Galactosidase activities of all reporters were oC1 Miler unit in the absence
of GAL. Drawings are not to scale, n.d" not determined, (B) Western blot analysis of GAL levels, Whole-cell extracts (21) were prepared from equal numbers of
SWl+ (CY296) and swir (CY297) cells containing the GAL overexpression plasmid pMA21O. Expression of GAL protein (indicated by the arrow) was identified
by Western blotting using an antibody directed against the C terminus of GAL (21),
recognition site both in vivo (10) and in vitro (3). As shown in
Fig. 2, these guanine residues within the four GAI binding
sites of the GAL1 lO VAS are protected from DMS methyl-
ation in the presence of GAI (lane 3) but are accessible to
methylation in an isogenic gal4- strain (lane 2). Introduction
of GAI expression plasmids into the gal4- strain restores
protection of these guanines (lanes 6 and 8), while introduction
of a plasmid expressing the bacterial LexA protein does not
(lane 7). In the absence of SWI-SNF activity, protection of all
four sites is retained (lane 4). Furthermore, as shown in Fig.
GAI also protects the guanine residues at each of the two
high-affnity binding sites in the presence (lane 4) and absence
(lane 5) of SWI-SNF. Similar results were obtained in at least
six different experiments with five independent DNA prepara-
tions. These results are consistent with the results of our func-
tional experiments (Fig. 1) in which SWI-SNF is not required
for the activity of GAI from either the wild- type GALl,
UAS or the two-high-affnity-site reporter.
Figure 3B shows the results of an in vivo footprinting anal-
ysis of the two-Iow-affnity-site reporter in strains CY532
(SYV+ and CY534 (swir). We detect little protection of the
two low-affnity sites in our footprinting assay, even in a SYV+
strain (lane 3). As discussed above, this probably reflects the
low occupancy of these sites at physiological GAI levels
because when GAI is overexpressed in this SYV+ strain
protection is restored (lane 5). Overexpression of GAI in the
absence of a functional SWI-SNF complex, however, does not
restore complete protection of either low-affnity binding site
(lane 6). This is most apparent at GAI site 3 , where strong
protection in the SYV+ strain (lane 5) and are only weak
protection in the swir strain (lane 6) are observed. Quanti-
tation of these results by phosphorimager analysis indicates
that protection of the relevant guanine residue in site 3 in the
swir strain is decreased (40%) from that seen in a wild-type
strain. For an internal control , we also analyzed these samples
for GAI binding at the endogenous GAL1 lO UAS locus. In
all cases, we observe complete occupancy of the four GAI
sites in the presence and absence of SWI-SNF (data not
shown). The lack of complete occupancy at the two low-affnity
sites in the swir strain indicates that the SWI-SNF complex
modulates GAI binding in vivo.
Introduction of an NPE into a SWI-SNF-dependent pro-
moter region can suppress the requirement for SWI-SNF. The
results of genetic and biochemical experiments have indicated
that SWI-SNF complex facilitates activator function by disrupt-
ing chromatin structure. To assess whether the chromatin
structure of the GAI binding sites was related to their SWI-
SNF dependence, a strong NPE was inserted directly upstream
of the two low-affnity binding sites in strains CY532 (SYV+
and CY534 (swir). This 182-bp NPE sequence has been
shown previously to translation ally and rotationally position a
nuc1eosome in vivo in yeast (20) (Fig. 4B). Insertion of the
NPE had a dramatic effect on the SWI-SNF dependence of
GAI function. While GAI transcriptional activity at the
parental two-Iow-affnity-site reporter was decreased over 20-
fold in the absence of SWI-SNF (Fig. lA, reporters b and c),
there was less than a 1.5-fold decrease when the NPE was
inserted (Fig. lA, reporter e). This effect of the NPE is not due
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FIG. 2, GAL can bind its sites in the GALl lO VAS region in the presence
or absence of SWI-SNF. In vivo DMS footprinting analysis of the GALl, 10 VAS
region was performed on strains CY341 (SWI+ GAL+) (lane 3), CY257 (swir
GAL+ ) (lane 4), CY296 (SWl+ gaI4-) (lane 2), CY296 containing a GAL
expression plasmid (pMA10 or pSD15) (lanes 6 and 8), and CY296 containing
a LexA expression plasmid (pEG202) (lane 7). Lane 1 contains a genomic
guanine sequencing ladder. Boxes to the left of the gel denote the GAL binding
sites of the GALl lO VAS and asterisks denote guanine residues shown previ-
ously to be protected by GAL binding,
simply to insertion of for ign DNA sequences directly up-
stream of the two low-aff ity GAL binding sites, as insertion
of 192 bp of pUC plasmid sequences at an identical position
does not alter the SWI-SNF dependence of GAL activity (Fig.
, reportersb and c).
, Nucleosomal context of GAI binding sites dictates SWI-
SNF dependence. The results of functional experiments de-
scribed above suggest that the SWI-SNF dependence of GAL
can be modulated by nucleosome positioning. In the case of
the GALl lO locus, the four GAL binding sites are main-
tained in a constitutive nucleosome-free region which 
flanked on both sides by an array of positioned nucleosomes (6
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7) (Fig. 4). This precIse nucleosome positioning at the
GALl lO locus is believed to require the GRF2 protein which
binds to a sequence that overlaps GAL4 binding sites 1 and 2
7). The GALl lO UAS derivatives that we have analyzed in
this study (Fig. lA, reporters b to e) lack this GRF2 binding
site , and therefore , they may not maintain nucleosome posi-
tioning surrounding the GAL binding sites. To confirm this
possibility, we analyzed the chromatin structure of the two-
low-affnity-site reporters (with and without an NPE) and com-
pared these structures to that of the GALl locus in the same
strains.
Nuclei and free DNA were prepared from the SWI+ strain
CY532, which contains the parental two-low-affnity-site re-
porter (without an NPE), and samples were analyzed by
MNase digestion and indirect end labeling. First , we analyzed
the chromatin structure at the GALl locus in this reporter
strain (Fig. 4C). Comparison of the MNase cleavage patterns
for free and chromatin DNA samples reveals a repeating pat-
tern of MN ase protections (each about 140 bp in size) flanked
on each side by MNase-hypersensitive sites. These results are
essentially identical to a previous study (6) and are consistent
with an array of positioned nucleosomes downstream of the
nucleosome-free GAL4 binding sites.
A similar analysis of the two-low-affnity-site reporter locus
(without an NPE) yielded very different results (Fig. 4A). In
the region upstream of the two GAL4 binding sites , the MN ase
digestion pattern of the chromatin sample is similar to the
pattern of digestion of free DNA, although we do reproducibly
observe several preferred cleavage sites in free DNA that ap-
pear to be enhanced in the chromatin sample. Importantly, the
MNase cleavage sites directly upstream and adjacent to the
GAL4 binding sites are cleaved with equal effciency in the free
and chromatin DNA samples. A region of about 80 bp that
contains the GAL binding sites is not cleaved effciently in
either the free or chromatin DNA samples; this is due to the
inherent sequence specificity of MNase I and is not due to a
positioned nucleosome (6). In addition, this protected region is
not flanked on both sides by hypersensitive sites. Directly
downstream of the GAL4 binding sites, however, a l40-
region of MNase resistance is detected, which is flanked on
each side by MNase-hypersensitive sites , suggesting the pres-
ence of a positioned nucleosome. The location of this nucleo-
some corresponds to a positioned nucleosome mapped be-
tween the GAL sites and the GALl TATA box of the
endogenous GALl lO locus (2, 6) (Fig. 4C and data not
shown). Thus, although one nucleosome still appears to be
positioned at this GALl lO UAS derivative , the majority of
nucleosome positioning has been lost. Consequently, nucleo-
somes appear to be located randomly upstream of the two
remaining GAL4 binding sites. In the absence of a positioned
array of nucleosomes, the two low-affnity GAL binding sites
are unlikely to reside in a constitutive nucleosome-free region.
MNase digestions and indirect end labeling were also used
to confirm that the NPE positioned a nucleosome upstream of
the two low-affnity GAL4 binding sites (Fig. 4B). Comparison
of the free and chromatin DNA samples reveals an MNase-
protected region of about 250 bp which contains the NPE
sequences as well as the MNase-resistant GAL binding site
sequences. This result is consistent with the positioning of a
nucleosome over the NPE sequence. In addition, the putative
positioned nucleosome located directly downstream of the two
low-affnity GAL binding sites is also detected at the NPE-
containing reporter locus in CY586 (Fig. 4B).
These results are consistent with the model shown in Fig. 6.
In the absence of the NPE , the two low-affnity GAL binding
sites are encompassed by randomly positioned nucleosomes;
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FIG, 3, SWI-SNF is required for complete occupancy of two low!affnity GAl binding sites in vivo. In vivo DMS footprinting was performed on strains that harbor
the two-high-affnity-site reporter (A) or the two-low-affnity-site reporter (B). The strains used were as follows: for panel A, CY529 (galr SWI+ (lane 3), CY528
(GAL4+ SWI+ (lane 4), and CY530 (GAL4+ swir) (lane 5); for panel B , CY533 (gaI4- SWI+ (lane 2), CY532 (GAL4+ SWI+ (lane 3), CY534 (GAL4+ swir)
(lane 4), CY532 harboring a GAl expression plasmid (lane 5), and CY534 harboring a GAl expression plasmid (lane 6). For quantitation of lanes 5 and 6 in panel
, phosphorimager data were normalized to the doublet band indicated by the arrowhead (G449 and G450 (numbering from reference 30)). Symbols and lane 1 are
as described in the legend to Fig. 2,
insertion of the NPE repositions the GAL binding sites into a
nucleosome-free region between two positioned nucleosomes
(see Fig. 6). To further test the possibility that insertion of the
NPE changes the accessibility of the GAL binding sites, we
investigated the ability of a restriction enzme to cleave a site
within GAL site 3 in permeabilized spheroplasts (Fig. 5).
Spheroplasts were prepared from the SWI+ strains CY532
(which contains the parental two-low-affnity-site reporter) and
CY586 (which harbors the NPE-containing two-low-affnity-
site reporter). Spheroplasts were made permeable by treat-
ment with nystatin (24) and incubated with HgaI restriction
endonuclease for 15 to 30 min. Genomic DNA was then
purified and digested to completion with HindIII and the
HgaI-HindII cleavage products were analyzed by Southern blot-
ting using a DNA probe from the GALl upstream region. Ths
DNA probe wil detect the HgaI-HindII cleavage products de-
rived from the GALl lO locus (1.6 kb) or the reporter locus (0.
kb) in the same DNA sample (see the schematic in Fig. SA). In
the case of the GALl lO locus, we expected that the HgaI site
within GAl site 3 would be highly accessible in penneabiled
spheroplasts, since this GAl site is known to be nucleosome-
free (6). In contrast, the model presented in Fig. 6 predicts that
the HgaI site at the parental two-low-affity-site reporter wil be
less accessible than the same site present at GALl lO. Further-
more, the model predicts that insertion of the NPE wil enhance
the accessibilty of the HgaI site at the reporter locus.
Figure 5B shows the phosphorimager quantitation of a typ-
ical HgaI accessibility assay. At 15 and 30 min of digestion
HgaI cleavage at the GALl lO locus was nearly complete (val-
ue set at 100%) (data not shown). However, in the case of the
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parental two-low-affnity-site reporter, cleavage of GAL site 
by HgaI was less effcient, indicating that these sequences are
less accessible than they are at GAL1 lO. Furthermore , inser-
tion of the NPE upstream of the GAL binding sites had a
dramatic effect on HgaI cleavage. Cleavage at the NPE-con-
taining reporter' locus was at least threefold greater than the
parental reporter locus, and the cleavage appeared to be even
more effcient than cleavage at the GAL1 lO locus. These dif-
ferences in HgaI accessibility are not due to the binding of
GAL, since similar results were also obtained when perme-
abilized spheroplasts were prepared from gal4 deletion strains
(data not shown). Thus, the accessibility of GAL site 3 to
HgaI cleavage correlates well with the nucleosome mapping
data and the SWI-SNF dependence of GAL activity (Fig. 6).
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FIG, 4, Nucleosome mapping of the two-low-affnity-site reporters with and
without an NPE, Free DNA and nuclei from the two low-affnity-site swr+
reporter strain (CY532) (A) or the two-low-affnity-site, NPE-containing re-
porter strain (CY586) (B and C) were treated with increasing amounts of MNase
and nucleosome positioning at the reporter loci (A and B), or the GAL1 lO locus
(C) was analyzed by indirect end labeling. The following amounts of MNase (in
units per mililiter) were added: for panel A, a (lanes 1 and 7), 0.005 (lanes 2 and
8), 0,05 (lanes 3 and 9), 0,5 (lanes 4 and 10), 5 (lanes 5 and 11), 50 (lanes 6 and
12); for panel B , 0.5 (lanes 1 and 3) and 5 (lanes 2 and 4); for panel C, 1 (lane
1), 5 (lanes 2 and 3), and 25 (lane 4). The schematic to the right of each gel
depicts the mapped locus, black rectangles represent GAL binding sites, shaded
boxes represent coding sequence of the indicated gene, and shaded ovals rep-
resent the predicted positions of nucleosomes. Restriction sites used to generate
the probe fragment are indicated on the map accompanying each figure, In panel
C, primers used to amplify the probe fragment by PCR are indicated by black
bars. Migration of DNA size standards are noted to the left of each gel.
DISCUSSION
In vitro experiments have demonstrated that the SWI-SNF
complex can stimulate the binding of an activator protein to a
nucleosomal binding site (5 16). Here we have tested whether
the complex exhibits this activity in vivo. We have shown that
the SWI-SNF complex facilitates the binding of GAL to two
low-affnity binding sites in vivo. Furthermore, we find that the
inability of GAL to occupy these low-affnity sites in the ab-
sence of SWI-SNF activity can be overcome by (i) replacing the
low-affnity binding sites with high-affnity GAL binding sites
or (ii) placing the low-affnity binding sites into a nucleosome-
free region. These results indicate that SWI-SNF is able to
facilitate GAL binding in vivo , perhaps by helping GAL to
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FIG, 5, An NPE leads to enhanced accessibility of a GAlA binding site, (A) Schematic of the GALl, 10 and reporter loci. The black bar denotes the DNA fragment
used as a probe in Southern blotting, The HgaI site is located at the 3' end of GAI site 3, +/- NPE, with or without an NPE, (B) HgaI accessibility assay, HgaI was
added to nystatin-permeabilized spheroplasts prepared from swr' strains harboring either the parental two- low-affnity-site reporter (- NPE; CY532) or the
NPE-containing two-low-affnity-site reporter (+ NPE; CY586), DNA digested in situ was purified, digested to completion with HindIII and analyzed by Southern
blotting using the DNA probe denoted in panel A. Phosphorimager quantitation of the HgaI-HindIII fragments is shown for the 15- and 30-min HgaI digestion time
points, The yields of the O, kb HgaI-HindIII fragments from the two different reporter loci are presented as a perccntage of the 1.6-kb HgaI-HindIII fragment derived
from the GAL1 10 locus which was set at 100% accessibility,
compete more effectively with histones for occupancy of its
binding sites.
A definition of SWI-SNF dependence. Our results suggest
that the SWI-SNF dependence of a transcriptional activator
protein is not an innate feature of the activator protein per se
but rather reflects the chromosomal context of the activator
binding sites. We propose that when the activator binding sites
are encompassed in a nucleosome, as in the two-low-affnity-
site reporter used in this study, SWI-SNF function is necessary
for the activator protein to bind to and activate transcription
from those sites (Fig. 6). On the other hand, when binding sites
are nucleosome-free, as is the case at the GALI IO VAS region
or at the NPE-containing two-low-affnity-site reporter, then
SWI-SNF function is dispensable for GAL activity (Fig. 6). In
this case, GAL4 can bind to its sites and activate transcription
in the absence of SWI-SNF activity. Furthermore, SWI-SNF
dependence does not appear to correlate with the level of
transcriptional activation (i. , promoter strength (Fig. lAD.
Thus, based on the results presented here, we predict that the
subset of genes whose expression requires SWI-SNF wil have
activator binding sites that are encompassed in nucleosomes;
genes that do not require SWI-SNF wil have such sites posi-
tioned in the linker regions between nucleosomes or in other
nucleosome-free regions. This positioning may be determined
by DNA sequence, as in the NPE-containing reporter, or by
abundant DNA binding proteins like GRF2, as in the case of
the intact GALl, IO reporter.
Our results also require that binding site affnity be incor-
porated intothe definition of SWI-SNF dependence. While
GAL4 requires SWI-SNF in order to access two low-affnity
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FIG. 6, Predicted nucleosome structure of SWl-SNF,dependent and -inde-
pendent promoters. Schematics depicting the predicted nucleosome structure of
the two-low-affnity-site reporter construct and the same construct containing an
NPE directly upstream of the GAL binding sites. Soli-line ovals represent
positioned nucleosomes; broken- line ovals represent randomly located nucleo-
somes, Nucleosomes located randomly over the GAL binding sites of the
former cause the expression of this reporter gene to require SWI-SNF activity, In
the NPE-containing construct , on the other hand , the GAL binding sites are
nucleosome-free and therefore reporter gene expression is SWI-SNF indepen,
dent.
binding sites, high-affnity sites are occupied even in the ab-
sence of SWI-SNF. The ability of higher-affnity binding sites
to alleviate SWI-SNF dependence provides strong evidence
that the SWI-SNF complex modulates transactivation at the
level of DNA binding. Furthermore, if these high-affnity bind-
ing sites are encompassed by nuc1eosomes, then our results
suggest that GAl binding to high-affnity, nuc1eosomal sites
can occur in vivo via a SWI-SNF-independent mechanism.
These results are consistent with those of Workman and King-
ston (28), who found that GAl can bind to a nuc1eosomal site
to form a tripartite transcription factor-histone-DNA complex.
Does the SWI-SNF complex play an additional role in tran-
scriptional activation? As noted above, we detect a consistent
level of GAl binding to the low-affnity sites in the swil-
strain (Fig. 3B , compare lanes 5 and 6); phosphorimager anal-
ysis indicates site 3 may be occupied at 60% of the level seen
in a swr strain (Fig. 3C). The fact that this level of occupancy
results in negligible levels of transcription (3% of wild-tyelevel (Fig. lA, reporter cD may indicate a role for the SWI-
SNF complex in transcriptional activation beyond the modu-
lation of activator binding. In light of recent reports suggesting
that the SWI-SNF complex may associate with the RNA poly-
merase II holoenzye (25), it is interesting to consider the
possibility that an activator-SWI-SNF interaction is involved in
preinitiation complex assembly. On the other hand, our in vivo
footprinting procedure does not allow us to determine the
extent to which site 3 and site 4 are simultaneously occupied
and we cannot distinguish whether the 60% occupancy in a
swi-snf strain reflects the stable binding of GAl in 60% of the
cells or reflects weak, unstable binding in 100% of the cells.
Therefore, our results may support an additional role for the
SWI-SNF complex in facilitating the cooperative binding of
GAl or in enhancing the stability of GAl binding to low-
affnity, nuc1eosomal sites in vivo.
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